var title_f27_17_27920="Brain MRI age 12 years juvenile Alexander disease";
var content_f27_17_27920=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F53244&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F53244&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Contrast-enhanced brain MRI in a patient with presumed juvenile Alexander disease, obtained at the age of 12 years",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 317px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note enhancement of the intraparenchymal trajectory of the fifth cranial nerve on both sides.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001; 22:541. Copyright &copy; 2001 American Society of Neuroradiology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27920=[""].join("\n");
var outline_f27_17_27920=null;
var title_f27_17_27921="Bicuspid aortic valve short axis echocardiogram 1";
var content_f27_17_27921=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/59607/biav1sax_conv.mp4?title=Bicuspid+aortic+valve+short+axis+echocardiogram+1\" style=\"width:328px;height:248px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Short axis view from an echocardiogram of bicupsid aortic valve",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 270px; height: 442px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Short axis view from a 2-D echocardiogram shows a biscupid aortic valve with two leaflets that move normally. The aortic root appears to be thickened.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27921=[""].join("\n");
var outline_f27_17_27921=null;
var title_f27_17_27922="Diabetic foot ulcer 3 PI";
var content_f27_17_27922=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F75848&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F75848&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Wagner grade 3 ulcer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The patient presented with a fluctuant eschar on the plantar surface of the foot. The abscess was unroofed and drained, and, following debridement, exposed bone was apparent at the base of the wound.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Thottingal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27922=[""].join("\n");
var outline_f27_17_27922=null;
var title_f27_17_27923="Spore surfaces";
var content_f27_17_27923=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F62506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F62506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    Spore surfaces",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 355px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Burge HA, Burge W, Muilenberg ML, Pan PM and Solomon WR. Airborne pollen and fungus spore identification: Hands On Workshop, Postgraduate Course, University of Michigan Medical School, Ann Arbor, MI, May 1990.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27923=[""].join("\n");
var outline_f27_17_27923=null;
var title_f27_17_27924="Sphincter of Oddi";
var content_f27_17_27924=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F78786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F78786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Sphincter of Oddi in relation to the ampulla of Vater",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 497px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagram of the anatomy of the sphincter of Oddi and ampulla of Vater. The muscle fibers of the spincter of Oddi surround the intraduodenal segment of the common bile duct and the ampulla of Vater. A circular aggregate of muscle fibers, known as the sphincter choledochus (or sphincter of Boyden), keeps resistance to bile flow high, and thereby permits filling of the gallbladder during fasting and prevents retrograde reflux of duodenal contents into the biliary tree. A separate structure, called the sphincter pancreaticus, encircles the distal pancreatic duct. The muscle fibers of the sphincter pancreaticus are interlocked with those of the sphincter choledochus in a figure eight pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27924=[""].join("\n");
var outline_f27_17_27924=null;
var title_f27_17_27925="Immunologic treatments for allergic rhinitis";
var content_f27_17_27925=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Immunologic treatments for allergic rhinitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/17/27925/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27925/contributors\">",
"     Richard D deShazo, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27925/contributors\">",
"     Stephen F Kemp, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/17/27925/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27925/contributors\">",
"     Jonathan Corren, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/17/27925/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27925/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/17/27925/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic rhinitis is an immunologic disorder that develops in individuals who have produced allergen-specific IgE in response to environmental exposures (most commonly to pollens, animal danders, insect debris, and molds). Briefly, these IgE antibodies bind to IgE receptors on mast cells throughout the respiratory mucosa. When the same allergen is subsequently inhaled, the allergen binds to and crosslinks IgE on the surfaces of mast cells and basophils, resulting in activation and release of inflammatory mediators that cause the signs and symptoms of allergic rhinitis.",
"   </p>",
"   <p>",
"    The treatment of allergic rhinitis involves the following modalities:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Allergen avoidance",
"     </li>",
"     <li>",
"      Pharmacologic therapy",
"     </li>",
"     <li>",
"      Immunologic treatments, when appropriate",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The use of immunologic treatments in the management of allergic rhinitis will be reviewed here. Pharmacotherapy and allergen avoidance and the clinical manifestations, diagnosis, differential diagnosis, and pathogenesis of allergic rhinitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37834?source=see_link\">",
"     \"Pharmacotherapy of allergic rhinitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/48/34569?source=see_link\">",
"     \"Allergen avoidance in the treatment of asthma and allergic rhinitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22362?source=see_link\">",
"     \"Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6775?source=see_link\">",
"     \"Pathogenesis of allergic rhinitis (rhinosinusitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     WHEN TO REFER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunologic therapies for allergic rhinitis are usually administered by allergy specialists. Referral should be considered in the following patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children or adults whose symptoms are inadequately controlled with pharmacotherapy and environmental control measures (avoidance, physical barriers, etc.) or have intolerable side effects from medications",
"     </li>",
"     <li>",
"      Children or adults who wish to minimize or avoid long-term drug therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SUBCUTANEOUS INJECTION IMMUNOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergen injection immunotherapy, or subcutaneous allergen immunotherapy (SCIT), is mentioned briefly here and described in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/8/39049?source=see_link\">",
"     \"Subcutaneous immunotherapy for allergic disease: Indications and efficacy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/27/27062?source=see_link\">",
"     \"Subcutaneous immunotherapy for allergic disease: Therapeutic mechanisms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1256?source=see_link\">",
"     \"SCIT: Standard schedules, administration techniques, and monitoring\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40327?source=see_link\">",
"     \"SCIT: Preparation of allergen extracts for therapeutic use\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    SCIT involves the administration of gradually increasing doses of therapeutic solutions of allergens to which a patient has demonstrated sensitivity, usually through skin testing. Over time, a dose is attained that effectively alters the patient's immune response to that allergen, resulting in fewer symptoms with natural exposure.",
"   </p>",
"   <p>",
"    Allergen immunotherapy is unique among treatment modalities in its ability to alter the pathologic process that underlies allergic rhinitis in a semi-permanent manner. Thus, when administered to appropriately selected patients, this therapy represents a powerful intervention that can significantly impact patients' lives. In children with allergic rhinitis, immunotherapy can help prevent the development of allergic asthma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/8/39049?source=see_link&amp;anchor=H14#H14\">",
"     \"Subcutaneous immunotherapy for allergic disease: Indications and efficacy\", section on 'Preventive effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SUBLINGUAL AND ORAL IMMUNOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sublingual and oral immunotherapy involves the application of allergen to the oral mucosa or sublingual tissues either in the form of solutions or dissolvable tablets. The",
"    <span class=\"nowrap\">",
"     solution/tablet",
"    </span>",
"    is typically held in the mouth for a few minutes and then swallowed. Oral forms of immunotherapy for the treatment of allergic rhinitis are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/34/1578?source=see_link\">",
"     \"Sublingual and oral immunotherapy for allergic rhinitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ANTI-IgE THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic inflammation appears similar in the upper and lower airway, and new antiinflammatory therapies explored in allergic asthma are potential therapies for allergic rhinitis and vice versa [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/18/20776?source=see_link\">",
"     \"Relationships between rhinosinusitis and asthma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recombinant human monoclonal antibody to IgE,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/46/38629?source=see_link\">",
"     omalizumab",
"    </a>",
"    (Xolair&reg;), binds circulating IgE and prevents the interaction of IgE with surface receptors on mast cells. Omalizumab is costly, and the US Food and Drug Administration (FDA) currently approves its use ONLY for moderate to severe persistent asthma in adults and children 12 years of age and older who have not responded adequately to inhaled glucocorticoids. Patients must have documented sensitivity to one or more perennial allergens. However, individuals treated with omalizumab for asthma may derive concomitant improvement in allergic rhinitis. The efficacy of omalizumab for asthma and the application of this therapy to other disorders are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/46/17130?source=see_link\">",
"     \"Anti-IgE therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical trials of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/46/38629?source=see_link\">",
"     omalizumab",
"    </a>",
"    in patients with allergic rhinitis have shown efficacy and safety [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/2-9\">",
"     2-9",
"    </a>",
"    ]. The following are representative:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One randomized trial evaluated the dose response of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/46/38629?source=see_link\">",
"       omalizumab",
"      </a>",
"      among 536 patients with seasonal allergic rhinitis [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/3\">",
"       3",
"      </a>",
"      ]. Patients were randomly assigned to the subcutaneous administration of placebo or omalizumab at 50, 150, or 300 mg administered prior to ragweed season and repeated during the season every four weeks to those with baseline IgE levels of 30 to 150",
"      <span class=\"nowrap\">",
"       IU/mL",
"      </span>",
"      or every three weeks to patients with levels of 151 to 700",
"      <span class=\"nowrap\">",
"       IU/mL.",
"      </span>",
"      Rhinitis-related symptoms were significantly improved among those receiving 300 mg versus patients given lesser doses or placebo. A dose-dependent decrease in serum free IgE levels was also observed, with the lowest levels being associated with the lowest symptom scores and use of rescue antihistamines.",
"     </li>",
"     <li>",
"      Another randomized trial treated 92 children (ages 6 to 17) with seasonal allergic rhinitis with SCIT for at least three months, followed by the addition of either placebo or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/46/38629?source=see_link\">",
"       omalizumab",
"      </a>",
"      for an additional six months [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/4\">",
"       4",
"      </a>",
"      ]. Both treatments were effective, although patients receiving SCIT with omalizumab had significantly lower symptom scores during pollen season than those treated with SCIT alone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EXPERIMENTAL THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Modified approaches to allergen immunotherapy have been developed with the goal of increasing safety, efficacy, or both.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     SCIT using modified allergens and immunostimulants",
"    </span>",
"    &nbsp;&mdash;&nbsp;An investigational form of SCIT exploits inhibitory IgG receptors on mast cells and basophils through the use of fusion proteins consisting of the allergen complexed to part of the constant portion of IgG [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. In cat-induced allergic subjects, a chimeric human-cat fusion protein was able to suppress in vitro and in vivo evidence of sensitization and reactivity to the allergen [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/10\">",
"     10",
"    </a>",
"    ]. More study is required before this can be applied to practice.",
"   </p>",
"   <p>",
"    Another experimental form of injection immunotherapy uses allergens complexed to immunostimulatory DNA sequences, which have characteristics of viral and bacterial DNA [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. These sequences interact with Toll-like receptor 9 on antigen presenting cells to promote a Th1 response to the allergen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=see_link&amp;anchor=H26#H26\">",
"     \"Toll-like receptors: Roles in disease and therapy\", section on 'TLR-based therapies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Intralymphatic immunotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intralymph node immunotherapy (intralymphatic) immunotherapy (ILIT) involves the injection of allergen solutions directly into lymph nodes by study protocol, rather than into the subcutaneous tissue (with subsequent migration to local lymph nodes) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. By introducing the allergen solution directly to the site of lymphocyte processing and interaction, similar efficacy has been achieved in small groups of subjects with smaller doses and less frequent administration. This form of administration is proposed to be both safer and more efficient. An open-label phase",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    study randomized 165 subjects to either conventional SCIT (54 subcutaneous injections over three years) or intralymphatic immunotherapy (three ultrasound-guided injections into inguinal lymph nodes over two months) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/14\">",
"     14",
"    </a>",
"    ]. Intralymphatic immunotherapy began to work within four months and showed equivalent efficacy at three years with fewer adverse effects. Subjects reported that injections were less painful than standard venipuncture. The cumulative allergen dose was approximately 1000-fold lower than that of SCIT in this clinical trial. Findings were similar in a small placebo-controlled trial of 15 subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Epicutaneous allergen immunotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epicutaneous immunotherapy (also called transcutaneous allergen immunotherapy) involves regular applications of allergen in a base of petroleum jelly against the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/17-20\">",
"     17-20",
"    </a>",
"    ]. In one protocol, the skin was tape-stripped and adhesive patches containing allergens were applied weekly for a period of three months before the onset of pollen season. This form of immunotherapy appears to be less potent, but safer than conventional subcutaneous immunotherapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Controlled helminth infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of allergic disease has increased significantly in developed countries over the past few decades. A possible explanation for this increase is the &ldquo;hygiene hypothesis,&rdquo; which proposes that the reduction in general microbial and helminth exposure during infancy and early childhood has altered human immune responses in a manner that predisposes to the development of allergic disease. The use of controlled helminth infection has been studied as a means of treating allergic rhinitis, but thus far, this approach has failed to show clear benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27925/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. The hygiene hypothesis and other treatments that are based on this concept are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/43/19129?source=see_link\">",
"     \"Increasing prevalence of asthma and allergic rhinitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31977?source=see_link\">",
"     \"Prebiotics and probiotics for prevention of allergic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergen immunotherapy is currently the only means of altering the abnormal immune response that underlies allergic rhinitis in a semi-permanent manner. Subcutaneous injection immunotherapy (SCIT) is the best-established form of allergen immunotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/8/39049?source=see_link\">",
"     \"Subcutaneous immunotherapy for allergic disease: Indications and efficacy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sublingual immunotherapy (SLIT) is widely practiced in Europe and other areas of the world, appears to be effective, and carries low-risk systemic allergic reactions, although few studies have directly compared SCIT and SLIT. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Sublingual and oral immunotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other promising immunologic therapies have been developed, although these are either not yet available for use in the management of allergic rhinitis, or remain investigational. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Anti-IgE therapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Experimental therapies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/1\">",
"      Agosti JM, Sanes-Miller CH. Novel therapeutic approaches for allergic rhinitis. Immunol Allergy Clin North Am 2000; 20:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/2\">",
"      Casale TB. Experience with monoclonal antibodies in allergic mediated disease: seasonal allergic rhinitis. J Allergy Clin Immunol 2001; 108:S84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/3\">",
"      Casale TB, Condemi J, LaForce C, et al. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA 2001; 286:2956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/4\">",
"      Kopp MV, Brauburger J, Riedinger F, et al. The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis. J Allergy Clin Immunol 2002; 110:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/5\">",
"      Nayak A, Casale T, Miller SD, et al. Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis. Allergy Asthma Proc 2003; 24:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/6\">",
"      Chervinsky P, Casale T, Townley R, et al. Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol 2003; 91:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/7\">",
"      Lin H, Boesel KM, Griffith DT, et al. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils. J Allergy Clin Immunol 2004; 113:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/8\">",
"      Adelroth E, Rak S, Haahtela T, et al. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000; 106:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/9\">",
"      Kuehr J, Brauburger J, Zielen S, et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol 2002; 109:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/10\">",
"      Zhu D, Kepley CL, Zhang K, et al. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat Med 2005; 11:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/11\">",
"      Kalesnikoff J, Galli SJ. Nipping cat allergy with fusion proteins. Nat Med 2005; 11:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/12\">",
"      Creticos PS, Schroeder JT, Hamilton RG, et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006; 355:1445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/13\">",
"      Hessel EM, Chu M, Lizcano JO, et al. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J Exp Med 2005; 202:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/14\">",
"      Senti G, Prinz Vavricka BM, Erdmann I, et al. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci U S A 2008; 105:17908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/15\">",
"      Senti G, Crameri R, Kuster D, et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol 2012; 129:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/16\">",
"      Hylander T, Latif L, Petersson-Westin U, Cardell LO. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis. J Allergy Clin Immunol 2013; 131:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/17\">",
"      Senti G, von Moos S, Tay F, et al. Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A&nbsp;double-blind, placebo-controlled dose escalation study. J Allergy Clin Immunol 2012; 129:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/18\">",
"      Senti G, Graf N, Haug S, et al. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol 2009; 124:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/19\">",
"      Agostinis F, Forti S, Di Berardino F. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis. Allergy 2010; 65:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/20\">",
"      Senti G, von Moos S, K&uuml;ndig TM. Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy? Allergy 2011; 66:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/21\">",
"      Croft AM, Bager P, Kumar S. Helminth therapy (worms) for allergic rhinitis. Cochrane Database Syst Rev 2012; 4:CD009238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27925/abstract/22\">",
"      Robinson K, Bradley JE. The allergy epidemic: can helminths supply the antidote? Clin Exp Allergy 2010; 40:1586.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7537 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-110.170.48.130-B1CD8C1B47-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27925=[""].join("\n");
var outline_f27_17_27925=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      WHEN TO REFER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SUBCUTANEOUS INJECTION IMMUNOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SUBLINGUAL AND ORAL IMMUNOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ANTI-IgE THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EXPERIMENTAL THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SCIT using modified allergens and immunostimulants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Intralymphatic immunotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Epicutaneous allergen immunotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Controlled helminth infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/48/34569?source=related_link\">",
"      Allergen avoidance in the treatment of asthma and allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22362?source=related_link\">",
"      Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/46/17130?source=related_link\">",
"      Anti-IgE therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=related_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/43/19129?source=related_link\">",
"      Increasing prevalence of asthma and allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6775?source=related_link\">",
"      Pathogenesis of allergic rhinitis (rhinosinusitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37834?source=related_link\">",
"      Pharmacotherapy of allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31977?source=related_link\">",
"      Prebiotics and probiotics for prevention of allergic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/18/20776?source=related_link\">",
"      Relationships between rhinosinusitis and asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40327?source=related_link\">",
"      SCIT: Preparation of allergen extracts for therapeutic use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/14/1256?source=related_link\">",
"      SCIT: Standard schedules, administration techniques, and monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/8/39049?source=related_link\">",
"      Subcutaneous immunotherapy for allergic disease: Indications and efficacy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/27/27062?source=related_link\">",
"      Subcutaneous immunotherapy for allergic disease: Therapeutic mechanisms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/34/1578?source=related_link\">",
"      Sublingual and oral immunotherapy for allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=related_link\">",
"      Toll-like receptors: Roles in disease and therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_17_27926="Prolonged QT";
var content_f27_17_27926=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66206&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66206&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prolonged QT interval due to hypocalcemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 99px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The QT interval in this case is quite prolonged (0.50 sec) at a heart rate of 55 beats/min. The rate corrected QT (QTc) interval can be calculated from: QT interval &divide; sqrt (RR interval). The RR interval is 1.05 sec leading to a QTc of 0.48 sec which is longer than the normal value of &le;0.44 sec. A long QT interval with a \"stretched out\" ST segment and normal T wave is most consistent with hypocalcemia. In contrast, hypercalcemia shortens the QT, hyponatremia usually has no effect on the ECG, and hypokalemia prolongs repolarization with flattened or broad T waves and prominent U waves.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAClAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6P0tpjZX+Yfm+0SYXd15q/OZPPtMRg/Mc/N0+U1R0gH7Lfjzwc3EnzYHy1fmBEtoBL/Ec8fe+U0zrq29o/n37CW7P9tugY8L8uDnrxWXqTP8A8I4SIwW85OM/9NhWpCT9su/nGPl49OKyNQDf8I0AbgZ85PnwOf3wpPYqj/Ej6xNadpPt9oNny4bJz04p0Ly+Zd5iHD/J833vlFNnP+n2n7zAw3y+vHWktxiW8zcZy/t8vyigx+z8v1Gq8otLQrEu4uAwLdKp7pv+Eux5Y8v7GPmz/tmps4s7LF1t+dctkfNzVVsHxacXZXNoPlyP7xoZvTS970fcsM9x/Yt2WiXcPMwN3UZNTyvP9rscxpglt3PT5aoKpOj3m6/Y5MmDleOtW5wv2uw/0s8Fu6/N8tApRV38+/YsSNIWuwyKAIxt568Gs7TDOPD+nkInmbkyM8Y3Va3KJ77NzuHlrgFh8vDVR0rB8OWCi6KtuT5gwz96lccY2h849+zNMmT+2CFVdnkDJJ5+8aooZ/7P1f5I93my4GTyNoq1hf7YLfaWz5I+XcMH5jVBVVtP1YfbWXMsnO5ePlHtQEF+nfuN1Uz/AG3QMrHzMc9ePkrUtvtH2673rGE+XaRnnisfVEX7boJF82BLyCy/N8v0rTt9gv7o/bmbhflLrgcfShFVV+7j6Po/5iq7XC+H7M7I/M3R/KScdatzNc/21aqFi2+RKd3P95P/AK1ZnyN4esx/aDZzH829c9fpV2RY/wC2LY/b3/1EnG9fVPakOUbN/wDb3R9ihpIu/setjbDuNxLgZPpWmPtYFgNsPTnk8fLWTpCxm01kG+kANxJzvX0+laTJHmwH9oSDHT5154+lNbF1177/AMn2LFv5/wDad3kRfcj55/2qzNWNz/wik2Vi3ZHGT/fFXIFT+1Lv/TpM7I8jev8Ate1ZmqiM+FJv9NfqP41/vjjpQ9iaMf3sfWPRnQSm4FzDgRbcNk80im58y4ysOAfl688d6jlRPtcGbyQEbvl3rz+lIFjDXJN9JyefnX5ePpVHKlp8uz7j5ftJW1IEW/eM9cY2mq0f2n+35eIdnkDnnPWnFY/KtQL98bx829cn5T7VBGqHxBJi9kz5A+Xcvr9KTNYrR+j6PuTL9q/s254izvlx1/vmppjc+ZY4EWNx3df7jVXUJ/Ztzm8cjfJzvXj5z7U+dUMlj/psgy/GHXn5G9qAa1fz6PsTg3Hnzhli27BgjPPWs3RvtY8O22xYdwJ4Of75q4qL9puf9OkJKDguvHXnpVDRlT/hG7fdeyAZPzb15+c98U1uVFWh849H2Zpn7T/aa8RY8k5PPrUB+1fY9R3LD1fA55+WpTGn9ooftkgPlHC7l55+lVnVWtdTxeSfx8Bl4+X6UiY9Pl08yLU/tn2fSsCAf6RFnrxV1Bdf2vIcQ48hM9f7zVnakiG30n/Tpf8AXxYw68/pV1YgdYlxey/6hONy/wB5vajqaSXuff0fcb/p39mXu7yPMzJ646VamN359thYeSdx544qkY4jpt6DfylMvlt6+n0q1Msfn2ub2TOTtG9fm4+lNIzlv9/R9ippf2r+2dYyIvvR46/3Kuf6SbGDiHfvTPXGM1Q0tY/7a1kC6fdujz8y/wB36Va2xrp8GLtym9Pn3j19cUiqq99f9u9P7pcYXH2tDiPbsbPX1FVz9o+zX+RF959vXpjvUzKv2yPNy4bY3G4c8j2qqyIbPUP9KkA3Pkhhxx9KZlBbfL8xbIz/ANl6bxFnbHnr021dUXPnsT5WzaMdc5rOs0Q6XpYN1J0jx8w5+Xp0q6iD7Y4F1KW2jKZGB74xSWwVVq/n08yNjcnTyWEW/wBBnGM1FdfaP7csMCLb5UueueqU5kj/ALKbF1IU7uWGRz0zimXaKdd0/M7hvKlwMjn7ntQyofE/+3unkW4fO8+5z5ecjb19KkXz/s8ePL38Z64xUUSL513iZ8kjdyPl4/SkURiygBncJ8uG3DJ9KZi1f8PyJ/3/AJx/1fl4985rNsTcf2dc8RBvPlx1/vmtH5PtTfvm37RlMjGPXFZeniIaZebZ3K+fLubPIO80uppD4X6rp6mlMZvNtsbMFju/75PSljEv2iYnbt42/lTZQpltj5rZ3HbyOflNLEym5nUSEsu3I9OKZl0+X6mfrAuP7LQfu9/nJu9Mb60G+0fao/8AV+XtOfXNZmsLCNGj/fv5fnJh88n560W8n7XFulbzdh2jPUetI2l8C06y6eg0C58i53GMHLbMA/rSuJilpkpuDDd6dDUatAIbzErnlt+WPHHamOYDDYjzX2hhtO45PB6mgmzvt+HkeW6b8SrlLG/2fD7xQ6NO7OBbjA56E5q/L8T70yWZ/wCFe+K+vy/6MP7p6c11+lNqpstROLUsJ5No55NX5Dq3mWeRZ5JO4fNx8ppanTVgud3a69fI4/wp8RINX8aS6Je+HdZ0nUJ7f7Qn22EKHVRg9K6S/aL/AIRnmF9nnJ8pTn/XCuS1ddTT406BJi1/eWNzGG5xwobp1rpdQOq/8I7nFmT5qcfN/wA9RSu7MqFNKcLNbx6m3cOn9o2eYn3YfB2dBim28kHmX4W3lxv+ceWfm+UdKrTHVv7QswRZhcPkjd1xSwnWPMvTiy3B/lGG5+UUzH2a5d1t38xpmtxYWANpMV8xdi+UTg5qBpLceMMm2lMhsxz5R/vGnIdY+xWRxZFi65BDcfrUf/E1/wCEqxmy/wCPQc4b+8fekzeMUubVbS6kqSwHR71RZzgAyZBhPXmrlxJF9qss2svVsfuuny1QA1ddIuyWsush6N0596szjV/tVlk2Octn5W/u/WmRKKu9V16+RIZIftF7i1lyY1z+668NVLTJIf8AhHrH/RZiu5flEWT96rDDV/OvMtZbfLGPlb/a96z9JTWG8O2IjazByuMhs/e+tF9SoxXJ8S3j18mbHnxf2r/x7TFjCOfK6cms8TQ/YNWBs5yDJIceV/sirONW/tU82OPJGflb+8feqgXVRp+q4ay+/Ln5W/uj3pMmEUuq6dfMh1eWL7b4f/0Sbibj910+WtO3ng+33eLKcN8uT5PXisfVRq/2zQNz2Q/fdlb+735rVtxrH9oXWXsduF42t6fWhM0qRXs46rZ9X/N6FJJIToFmPsM/VOPJ96vSyw/21an7HNnyJefJ90rP26uugWgL2ecx4O1s9eO9XpV1b+2LU77LAhk42t6p7/ShMU0rvVfa6vsVNMkh+y6x/oku0TScGHGeKuNPDmwP2G4OOmIOny1m6b/azWms7WtA3nSDlW64+taKrqxFhmSzyBz8jf3frQnoOrFKb1X3vsT20sTancj7JKuUj5MXH8VZertCPCdwPssnBHAi77xzV+Aap/a13+8tNuyPA2t/te9ZWsJqn/CJzZktuozhTnG8e9DYqMV7WOq3j1ZvvNG15ADazZIb5jFwKXzIg1xm1lPPP7rrxUEqap9sg/fWmz5sjYf8aAmq5ux59qSfufIeOPrVXObljZarbu+/oK80LRWZ+xTYMg+XyeR8p5xUUckQ8QyD7NKD5A58rjrSGLVhDZAzWu8ON3yHptOe9RImpf8ACRy/vrfZ9nH8B/vfWk2axjG0veWz6vv6FhZYv7OuR9llI8yXjyuvzmpppIhJY/6LIfn4/d/d+RqqxxamNOuR51vkySlfkPHzn3qSSLU/MsMz2/Dnd8h5+Rvenclxjd+8uvV9vQmDx/abnFrL9wc+X168VQ0R4v8AhG7bNpIwBPyeXk/fNXgmo+fcbprcqUG0bD1596y9Fi1M+HLdUmt9+TyUP98+9F9Sopezeq3j1fZmz5kZv0H2eTPlnDeXwOelVi0Zs9TxbuD8/VOvy04x6j/aSET2+wRHcNh5OfrVd49R+yalmeDB34Gw8fL9aLkRitNV06vv6DdRMRt9J/0aT/XxY/d9PrV5Cg1iX9y3+oTnZ/tNWXqUWo/ZdJxcQ7hPFk7D/jV2OLUP7XlJuIMeQv8AyzP95velcuUVyfEuvfv6CM0f9mXv+iSdZPlMfXirUpjNxa4tn4J58v7vFUHg1UadeA3dvv8An58s+n1qaeHVfPtcXUGATu/de31p3JcY3+Jder7egzTDH/bWs/uGHMfOzr8tWd6DT4D9lkA3qPL2cjnrWbp0WonWtXxcwjmP/ln/ALP1q0ltqv2KISXcXmB1PEXbP1oTKqxjzK8l9nv29DRYqb2P9033G+bb05FVWK/YtSxCThn+UDluKJYNRN5GUuogmxs5j9x71TNvqZtdRAvIuXfb+66cfWhsyhCOnvLp37+hZsmU6VpR8huRHxj7vy9a0Vx9pceUQQo+fHB9qxbC31D+zNNzex4Cxk/uu2361fEGo/aGJvIzFt4Hlc5oWwVox5n7y69+/oOkI/s1j9mZf+meOTz1qK7bGv6ePKLfupvmHQcpUc9vqf8AZ7L9rjMvr5fvUNzBfnW7DF3Hjypc/uvdKTHTjG795fa79vQ1Im/f3X7o8Ef8C4pqSH7FAwt2JO0bOPl96rpBf+bc4vE5I25iHHFNW21MWsSi+jDDbuPk9qZHJH+ZdO/b0NDeftRXyTjbnzOMfSs/Tm3afdfuCuJ5Rt4+b5zzU32a+80n7au3A/5YiqFhbagLC6H21d5mk25iGPvml1HGMeV+8t138/I15mImth5ecsef7vymkiZvtNx+6wPl+bI+biqcttf+dbH7euAxz+5H9006K2vhcTk3ykHGP3I9KZPJG3xLbz7+hBq0rrpKk2xJMyjZuHHz1os8n2hP9Hz8p+fcOPasbU7TUf7NUG/Ut5q5/cj+/WgbXUPPQjUB5YU5HkjOaDSUYci95bvv5eRKJJDDc/6KVA3fxD5qY8k3lWh+ynO4fLvHy8Goja3/AJM+dQHO7b+5HFRyWeo7LUDUfmDDd+5HoaCVGHdf+TdippawfY9RzeyhftEnzeb0q/LHCZLMC9lxkkHzevymqOlSr9k1EGxnI8+Tjy15/Wr7yr5loBZTjkgZRePlPvQjarfnfz7djjNfjhPxV8Ln7VJkpdLxJ0Hkg10F+kQ8OH/TJMeanzebz/rRXPeKZlT4l+EWa1mUebcgHYvzEwdOtdFfyg+HSPsU2PNT5di/89R2zStuaQvzQ9Y9vM0JkhN/aYvJCcNgeb14pIY7fzrz/Tpfv8/vunyinTzAX9oBZTdG52Lxx9aIZV867/0Cbl+fkXn5R71Rz68vy8u5WSO3FhaD7fLjeuGM3J5qEJB/wlGPt02fsg/5bcfeNWElT7DaZ0+c4cYHlrxz9ah85P8AhKgPsUufsgP3F/vn3pM2jf3vR9iXy7cabdYvpSCJM5mzjrUtwkIurL/TJuS2D5vX5aY0q/2Zd4sZhgP1ReevvU9w6i5sv9DlPLY+QfL8v1pmbbv9/bsMdYPOu/8ATJOIhn970+9WbpYth4dsgb+ZQWXkTYP3q03lUz3i/Ypv9UvOxefve9ZelTIvhqwzYyt8yj7in+L60uppC/J849uzNPZB/amDey7vKHHm9eTVKOGA2GrD7bNjzJMnzv8AZFaQK/2r/wAej8w/e2jjk+9Uo3X7Bq3+iSf6yTjaOflHvQRCT/Lt3KWrRQC50IfbJiTPwfO5+7V+1jtv7Tu9uoTlgEyPO4FV9VdftWhYs3/13XaPl+X61ftX/wCJneA2MijC4baMEfnQtzScn7Nej7fzGakMB0C0Y3s+3Kc+b71flii/tm2H2ybcYZeBL7pVRJS3hy0P2OXO5Pl2jn5uvWtGVh/bFri3b/Uy/NgccpSRM2+Z/wDb3bsZGkRQNa6z/pkxX7RJn977VoNHCV07ddzD0Pm9flqrpD4h1oi0cYuJMDaPm4q+zhRp/wDorEHtx8vy0LYdaT9o/wDgfyhBFF/al2RcybvLjBHmf71ZOrJD/wAIfPm4kZcjrJzneK1oJX/te9AtXwEi+bjn71Z2qsw8Hzt9nIfj5eP74olswo3VSPrDsa1wkf2+2Bmk3YbAD0kCQ+belZ5TyN/z5x8vb0p11MYrqF5Igsaq7NIzABAB3NJZ3K3CXEsCJJGcFGRgyyDHUEVRy3fL8v1GusDW9lmaTy967G38k4OMmoUEf/CUSDzG8z7MPl3dt3pVovIILQi2BJcApn7vB5qshceJnHkjBth8+f8Aa6UmXC/vej6ruKEiTS7s+bJs8yXcd3Q7zUsqxCTTcyP9/wCT5uv7tv6UZkOm3P7kZ3yALnr8x5p1wziXTgIlPzn+L7v7tvagV3d/P8gXyxd3eJH3BBuG7pwazdF8g+FrYvK4iycNuwT+8NagaQ3FwPIX7g53/e6+1ZmiSTf8I1bkWwJyfk3dPnPtR1Ljf2fzj1XZmiyxDV4iZG8wwkKM8EZqNljNpqgVmOS+/J6fLU7tJ/aKAQgjyiS27pz06VCzym01DMSjBfA3fe+X6UGcb6fLr5lLVUh+y6NudwouItvzdfrWggX+3JTk7/s6cdsbmqlqbTfZtLPkKT9oi439P0q+hf8AtWXMY/1C87v9puOlIud/Z/f180VZRbjR78bm8r95k5Oc4qxcfZxLZ7iQ275OTzx3qKSSb+zL4+Qm4eZ8u/rx9KsTSTiS3H2dGyeT5n3ePpVEu/59V2M3SvIXXtb253Zi3df7tWT9k/s2HBbyQ64POc5qDTWmGt6wRCvWL+Pr8v0q0Zbj7HETaoG3r8vm+/0pI0q351/271X8pM/2f7ZGxH7zY2OD0yKpt9lNpqQb7u99/X0qa81AWl7bJcG3i87KRmScLvbj5QCOTUZkuBa3+LaMgM//AC168fSgzgnp8uq7kNp9kOlaUSOAI9vB67avqLT7UxA/e7Rnr0qpYzXK6VppW3jOUjBHm9Bt+lXhLc+aV+zJtx97zf06UJaBVvzP59V3KUqWP9mt8p8vv1znNR3gtP7d08uvzeVLjg/7FWpprtrNm+yxhv7vne/0qG5e6/texIt4z+7lz+96fc9qTLpt33/m6rsSwi08+6AUdRu4PpQFsfscOV/djbt4NPgkuvPuSbeMHIx+968fSnRyXQtoiLaMtgZXzen6UzN3vv26rsGLNbk8fvdvoelZlktiNPvPl+Xz5N3B/vmtfzLnzSPs8e3H3vN/pis+xkuvsNzm1jz50mB53X5z7UdSoN8r17dUWJ1sxNa5UZ3Hbwf7pojSy+0zkIN+Bk4PpUkkl15kOLaPG45Pm9OD7UqSXP2iYfZ02jGD5vXj6UyLu2/Tuu5kasLAaSpCfJ5y4GD/AH60HTT/ALTEDGN5U7eD0qtqsl2dMBa1jV/NX5RLn+P6VoNJd+emLaLbg5bzeR+lFjWTfIter+0vIqrBp5hudsfdt2Qaa8WnhLUCP5d4xwfQ1deS6CSYt4+Acfvev6VznjXxanhSw0y71K1ylzeRWoCS/dZ+B26UnoRGUm9//Jl2LulC9FpqJMkJP2iTHymtKUXRltCHhHPPynn5TWDpWn2Is9S/0q78sTvu/wBKk/xq/Lp1iZLLN1edfk/0uT+6fehXOisoc7/+R8vU5bxtHcf8J74OkMkIUX0gAwc5MNdLfi6Hh0/PDv8ANTnBx/rhXG+PLCyj8X+E5PtF0ZP7UWM5uX4DR8c54ro9Q0+xHhok3FyU85ety5/5ajtmp1sy6aheGvWPT18zoLhbr7daHfFtw2flPXFOhF15t388Odw2/KePlFUJ9NsxqFmPtF1uw23/AEp+mPrSQ6bYNLe/6Td/ew/+lSf3R71Wpz2hyrXp/L5+pMgvPsFn+8h3eYuTtPPNeZ2Oo3j/ALT+oWTXA8pNET93zt6hunrzXcf2bpn9nWG6e52+YoX/AEl/X614zpkFi/7VN+vmzGEweQp85slhChI3ZzjPapbehs6cXzNX6/Z/4J73suxpV3mSIsfMIO08DmrMwn+1WWWj6tu4PPy1hx6dpg0m9KyXBUGTOZn68+9WpbDThcWADzFWLbczOf4frTuyJQjd79fs+XqXytx9qvfnjwYl2jB4+9WVpsV23hWyRZYlfcvJXtuqRtM037Tfj97xEu796/8Ate9Z2m6XpjeFbJpBJ5ZZed7dd1J3uawUFHd7x+z5PzOnAm/tPJZNvkjIx7mqaCb7Bq2HTd5kuDjp8oqAaPpi6rjyn3mLP329T71WTStOGn6sdkhVZJM5duDtHvT1Moxp930+yu/qW9UEn2jQvnXiYbuOvymr1qbj+0rsM6FAEwAvTg1iajpunLPof7twWmG0bjz8tXYdF0ptRutsTGXC7xvbH86NRzVP2au3s+i/m9RqrP8A8I3ZgSoJNyfNt4xmr8wm/tm1+dAvky5G3rylc82j6T/wj1s3lyeXuTJ3N1zzVqbRtK/tm1Tyn5glON74PKe/1palyjTu9X9r7K7eo7SBdG11vEybxcSbTt6cVoLDcsmnEzLlcFvl6/LXP6Vpukraa0VtztWZxyWPatJ9N0t4dOZ4SAQMfe5+WhXsVWUOd2v/AOAr+X1NO3SX+17wmQbTHHgbf96srV0mPhC4BmG7I5C9vMFPttL0kavdgW2W8uM4IY/3qzdVstKPhCdhbKFBGDtOc7xQ9hUYx9rG194fZX+ZF8YpLi38Ca1LDPs/0KVMAddwC/1rK/Z5eeb4SaK8k2f9HVFGPu4GKX4x6bpP/CJyRtbhHleOJSoI+9Kg/wAay/gBp+mj4dvDNbiRoLmaFiyEnCsRxR1M1CPsd39y7+p6pIkohtB5/wA4cZbH3uDVdUf/AISRz5vH2YfLj/aqi+naI1pak2SbC6gfuznODUK6ZpP/AAkjqbKIj7MODHkdabFGELS1ez+yu/qa4jl/sy5HnfMXkwdvT5zUlwj+bp3708SHPHX921ZC6bo4066/0KIjfJnMX+2elPl07RhJp/8AoMQ+c7f3XX5G60C5I3er6/ZXb1NYJJ9quT5pwUGAB061l6EkzeF7cCch8t823/poaP7O0YX1yDYw52An91x36Vm6NpujHwxCz2MTAlufK+b/AFh70dTSMIez3e8fsrs/M6rY/wBsU+aeIyCMdeetVikgs9QzKTkvg46fLVM6do/9owr9ggz5R2/ueOv0qL+zdH+z6gRYQ9Xz+6/2e1PUxjCK6vp0Xf1LGpRy/Z9LxMeJ4snb1q6qv/a8n7w48hOMf7TVg6hp+jiDS9thAA08YH7nqPfiryaZpP8AbEiiwt8+Qp/1Ix95valqXKMeTd9ei7+pcaN/7OvVMxJPmfNjpxUtxFKZbbFwQFbkbR83FZLaXpDaXesNPg2DzP8Allz07VJcaboqyWwOnwctwBD7d+KepPLG+76/ZXb1JNMgmGt6wzTHaxj2/L/s1aEcps4R9pJO9fm2j16Vh6fZaQ2sarE1jAY4zGVUwjC5XnHHfFSDTtBFhEf7OgCeYv8Ayw5+9QrmtSEXJXv9n7K7ep5l+0xLcQX/AIEaCYgrqyNwBx0Gf1r2DyZfsmoA3J5Zudo4+UV4f+0Rp+mHUPDqW1jEnls077IQMgOg549zXrNtpmhSabeMumW4GCf9QP7o6cVOuooxjyLV/wDgK7+pqWkUh0rSv9JIwsZztHPy9K0PLl88/wCkHG37u0fnXO2mlaIdM0xjplsSRHz5Aznb34rQXTNFNyyjTbbdtyT5A/wqlexFWMLvV9fsrv6lp4pfsDD7Ux/2to9aZdJL/a9iv2gjMcv8I5+5VFtM0IWLFdMt9menkDPX6VHdaXow1mwX+zrbmOUgCAY/h9vrQ7hCML7v7X2V29TZiik+0XJ+0NyRxtHHFNWKQWkIF0R93DbRzVGLS9HNxdf8S224xn9wOePpSLpWjfYoGbTbbbhcfuBkfpT1ItC+76fZXb1NYRS+dn7ScY+5tH51m2Ucg067H2kk+fJ82Bx85p39n6R9r2f2db79u7d5A/wrP07T9JaxvD/Z8OBPIDmHn71LW5UIx5Xq+n2V5+ZuyxuJLbM5yGPYfN8ppIkf7XPm4Jxt+XA44qnNpuk+dbA6fbksx2/uRx8p9qItN0r7VcAWFvuAGT5I54+lPUztG2727Lv6jdWUnSh/pmB5q/Pgc/PV90YSxE3eOD8uB83vWHqOn6QNJVxp8IQyrgCEA/frTfTtL8+INYQFsHafJGAPypalyUVFavd9F5eZMqsY7g/bNwy2eB8teI/tS3jW/h3wwiXW8/2lHLjjnZzmvZV07S/JuCthAPvbv3I5/SvDv2lrCye00OK0s44ykU87BY8HaqUpXsVSjGU7K/3Lse1aS7C11E/ZGJ+0SfLlef1rQld/MsyLVsk88r8nyn3qnpUcq2upASgM08hU4+7V6VZPOsv3o4J3cfe+U1RnVa9o/n37HE/EdnGpeG3W2ZlTXLX5ht7gjFdDqTsPDZItmJ81Pkyv/PYe9c58WpXsdKh1SS4WO1sNTs7qUkcIit8zH86121G11DwiLiw1S2uYmlUrPEwZSPOFS3ua0rXh6x7m7cO39oWf+jtjD5OV44+tOtndpLzNqykPxkr83yj3rzbxj8R54vFMWj+CtPfxHqltGzXEcDgRwk8AO/TPtXMeHvjXfnXGi8U6JLoWlz3DWbX05+WG5VBlD7e9HMZqk3BPTbz7nsnmSfYLIiy5Mi5Usvy814JoVxL/AMNC/aTbjM2o3kIwR/AAvX/gNe6L5sulaZKl4pR5EbcAMMCeMV4A1r4gjvdP8V+GrL+17tNQvb0W6sF3RPPJzn6DNKT2OujFWnttLufQxkmOj3n+jKMeZxuGD19qnuHm+12H+jr1b+P7vy/SuW8C68fFPw/OrrJJA1wJd0T43RMCQVP4iuqnRvtVgPtB6tnp83y07nLJJSe3Xv2E3zm8vgYI8eUmDv6/e9qz9He4XwzZEW6Egj5d/wDtdelXwjfbL3/ST/ql44+X71cZq3jHQ/C/g+2k1bWo45htKwRsrSyHd91UHJpN2ZcUnG2m8e/ZncF5xqu0QoU8kZbf05PtVdGmFjqZMaE75MAP1+Ue1eV3njzx9f3bX3hrwVcNp6RBhHfSrFNMuT8yr/SruhfF7wtd6DfPq2rLo+ol5BJY3nyzRNgDbjHrRzEqnZLbp3PQNWeQXGiDykJM4yd3T5T7VpQPMb25UxIAAuG39f0rjLjxl4Zvv7BntvEmnSJ5oO4Tpz8p6+lacHirw+t/csfEunkEL8puEwOvvTTQppezXo+/8xf8y5Og2rCCPflMLv8Af6VdmM39q2uI4yfJlz859U9q5MeKdAGg2o/4SawyGT5vPTPX61cm8WeHRq1sT4m07Hkyf8vMeOqe9K6HJK7/AO3u/Yv6Z9oWDWMQxbjPIceYeePpVwPd+Xp5FvCTxn96fl+X/drl9F8TaJcDVYovEdi8slw4jCzpk8cYGeateKfEem+GNBtNS1PVGWCPaAsZDPKxHCqO5NNNWLqJOb2/HsdFC91/aVyPJh27EwfNP+1/s1kas91/wiM+YIu3AlJ/jH+zXleq/EH4iRTPqWmeDJ3sLgxxwwSuBOAc7WZR90Gt/wAIeN7Txb4DvImuja65aYS9sZCBJC3mDt3X3pNl0qaVSG28e5r/ABde8a00KBIYiZtUgXHmE5w4bH3faoPgp9rh0PX4PJiDQ6zdpgyEYO/p92rnxEjebxJ4LtVuG+fUTIcY4Cxsc/rXHWmseIPAHjLVbXWbAf8ACLarqzvDqUcqlonm5XevYE0dbmS5XSUVa9vPuexb7zybYmCAybhkeafQ/wCzUCNc/wBvv+6hx9nH/LQ/3v8Adp4hc2toPtj53D5xjng1Esbf8JC/+kt/x7j5eP71UyIqPvbbPv3JQ93/AGfOfJh3b5MDzDz8x/2adM935lhmGH/WHP70/wBxv9mq91NDa6Rdy3GoLFEpkJkdlAX5j3rzjxJ8TUu9VsdF+H4fxFrQJZjEwFvENhGXk6Z5zik2gjFSb0XXv2PTxJe/bLgLBAQEXH74+/8As1Q0KW7/AOEahZYYTJluPNIH+sP+zXlN5qHxb0G5Gq6hHYataAj7Vp2nqDMiHOCuepFS+GfjL4Rfw0kGo6vc6XfxOyzW1xCQ6HeT6YPWknrqbezjyWVt49+zPZGe6+3RjyYdpjOT5p4Of92ome6Ntf7ooRjdjEh5+X/drz5vjF4F+3xN/wAJQu0RkH92cfjxWpa/EPwfdWV28Xi7TWWQMVDXCKR8voeaq6MFC1tO3fudLqLXJt9N/dQ58+Mn96f/AImrqNN/akmY4wPJXkOf7ze1cVqXjvwm1vpoXxbpZKzxk4uUPHqeaux+PvCJ1Z2HivSSDCox9qjwfmb3pXQ5L3Nu/fujo5HujY3mIot3z4HmH0/3alnkvBJBiCDBb5v3x44/3a5NvHXhP+z7xV8W6WWbfg/akz0+tY3iv4jQy3umaV4EuLfX9cuWJWOCZTFEoHLyMOgp3QlG7tZde/Y7fTmuhrmrHyYcHyv+Wp/un/ZqZXvvsMP7i33714844xu/3a8O/wCEn+LGgXmv3GpaJp98lmkc9zJbyYBj5+VB3IGa9S8HeJNP8U+DrHVNO1LdFI67/mG6Jt3KN6EUJ9zapBcyen2e/Y4v4vzXNx4jmhEEDfZNGecjzCcZnTn7v+zXpemz3c2iyyeTCGZMgeaf7g/2a831XTpvE3xK8Y2Vpe4ZNGjskY42+YxL4P5rT/hn4o1GO+1vwb4xuLa116xiV4PKcbbiIp95c9SMDIqbi5VypadO/c9Ks5LsaVpeIockRg/vT02/7taINz53McPl44IkOc/981nWS50jSf37EERYbjn5a0lXFyT57E7fucfnVLYwrW5np379yFmuzbHMUPmZ/wCehxjP0qC6M/8AbVjtSPHlS5y5/wBj2oup4LbTXe4v1jQEgyO4GOema4PxL8WPBula7Zh9cW6liSRGisl84liVwDt4zwaG0OnH3tF/N37HosTTma4zHGCCNvznnj6URtci2i+SLfhc/Of8K888P/GLwRqt5cxf24LGdmwI79TAQQMcbuK7y2uLefTbdob5HQhCsiuDuzjH50XRDjbddu/YtFrj7QQI4vK29d5zn8qo6e901pdZSLcJ5AvznpuPtWgADctiU7tv3M/rWVpgjWwvR9pZh9okyc/d+Y0dRwtyvTt3NGZpvOtvkjwWO75z/dPtSxGb7TOGRNvGCGOen0ps5UTWpMuMMe/3vlNEUkZurg+eOi8buBxQRbTbp+pT1Q3LaVnbH5nmrn5jj749q0yZPMQBV2EHdzzn2rhfiB4z0Lwr4bV9S1DfK8gMMER3yzkPnCgV5/qvxl8UR6pbSweBL+LT0ja5kM0nzGDu2B0YelJyRs6Upxsl1f6HvDGXypchA3O3n8s14v8AGxLm81eG3McbmLRbuVvmOASuK9L8KeJNI8T6CdT0a/E9tOCx+bmM45BHYiuN1nTLbxB421K1jvjlNKFqGLZGZM9aHqtCsOuSd5Lby8jrNO1Gxa01LeszIZn3fu2zir0uo2O6x3RzYB/d/u24+U0ukG5EF+RFDv8AtD4G44P6VelNx5lr+7izn5vmPHynpxTKqyhzvT8fL0Mm5fSdRlv7a/tPtMUqqJI5oC6suOhBGK8v1f4ZfD19IluodKurV3lXcLeWaNT+8APyg7entXpmqeK9I0TVJrfWdV0uwkcK0a3FyI2fj0NZHinxZpGleHIv7R1PS7WSd0kiSa5C7180HIz1HepdrM0oNc8VZ2vHr/wB3h/SvC3hdrGz0DTPscOHJ2ROS3HVmPLH3OadrNn4b12w1ex1ax+02szfMrwFsHYPmHHBHY10c008l9p7wpA8TqzBw5PG3jHFFu1402oAxWw+cD755+RfamSpx5b67fzf3vQ+dNR8NeMfDXhyGLwl4ik1OxMirb2V5ZEvGCcYD+g616p4NstL8PPpGlGCWV7TSo4Xb7OTvcfebGO5zXWj7b/Z1hiK2JEqfxn1+lITe/8ACVj91bf8enXe398+1TY6faxtJLtL7X/APGdS8I63YP4ivPBuufYbG9nef7Bcab5io3fax+6D7Cp5NB8fXQ05LrxfBbs4IPkaIuY+OcEjk17Ju1D+y7vdFaD/AFmMO3Tn2qxO179qs/kts5bPzt/d+lPlIdZJ7d/teXoeD2fwu1H7bqsd5498RyQyqDJ5dpsZ+vGSTt4HbFdX4K8GeCdB8P2s8Hh/zr1mUyXVzbtNIzbuu5s4/wCA4Femg332u6/d22PLXHzt/te1UdGN8PDlpiO2LDHV2xjd9KFGz0D2sXG77x+15PyF+2ad/aQ/0GTd5QAP2Y8cn2rFm03wzdQ6pLc+H7WWVpJMvJp6sx4HcrXWKbz+0PmSDy/LGSHOep9qrA3f2XUcLAfnfHzH0+lVYwjOP5faOC1fwf4Ee60gnwpZKXmGdtgFDDb3wOasxeCPh+b24B8I2ZIC8fYeB9OK63VWuhPo2Y4M+eM/OePlPtV+I3v2yfMdvtwuDvbJ6+1Kxc5x5F6P7Xmebx+CfAX9hQOvhO0OWTLGy5PPPNWZfBPgD+1bdf8AhELPBikyPsHBOUxxj6/nXZg339kWwEdtkFP42x1+lWJmvP7VtsJb48mTq7eqe1Fgc43f/b32vI8qX4dfDu6i1c3HhVSRKwUxRSIUA6AbSMVa0f4d/D3SLvS7+z8My/aUIZWlE0oBx12uxGfwrvNKe+K6vlLUsLh8fO2On0q8jXhisTst8kAn52/u/ShIqpKKk9P/ACby9ChFd6b/AGnc/wCgyZ8uMf8AHqf9r2ryn4neA9G1/TE1vSBeaLrdscC4trYKso38+YABu+pNe0w/a/7QuCUg27Ex85z39qyNZ+2f8IjcgrBnHUMT/GPalJaDoTi6kV5x+0eZeBPCuraJ8QmufEN/d61pkUBFlJcWoDrI33zgD2/WvQfE+kaP4n0PV9Lv7OZYLhQpeODbIpA4ZTjgiulmN19tt/kg24bPzHPT6UK115t1tWDII25c+nfimo20MJ1VKzt07+Z4Y3w61/T4LR9I8c60FLhRHdaekwRccdepFJL8M7y414W91418TSRtb5naOFUZ8nouB8or3KN737NBlLffkZ+c4/lUC/af+Ejc7Ytv2YfxHP3vpS5EbRxHxej6nk1l8IPBMVvNcX9rrupeU74ivbiRkJDcHAxk/WvQLKz0LSU0yLStBjtIt5O2CzVP+WbdcDmt9jcnT7jKwht0mPmOMbj7UsxufN0/iL/WfN8x/wCebe1Oxk6qbb9evkZ0VxYG/uv+JdJ9xSf9HHPWsTS7fRn8ORvLoaSszMSTaKx/1h74rr4zcfbrj5YsbF2/MffrxWdoy3Q8OxoghEgZ/wCI4/1h9qLO5aqLk+cevkylJaaG9/CraBEd0bdbJOn5Vj/8Ix4PePUv+KM07cC3zf2ZF/d7ccV3DC4N7CQItgQ7uTnPtxURM5t9Q3CPq23k/wB3vTszKNSOmnbr5nB6l4V8HLaaXt8G6cu6ePONNiBPqDxzWhH4T8HDV3UeDdLH7hSB/ZkWB8zdttdFqf2j7NpefK3faIt2CcVfTf8A2rJ93Z5K8Z5zuakVOceTbv180cOfCfg86Vet/wAIZpowZMf8S2LI49ccVrWOk+HdImhfS/DNrZySEAvb2KRnp3IAzW4fO/s6+yY/M/ebeuOnercvm7oNuzG75859O1MiVRX279fI5yxubU61q27TpTjywf3AP8JrybxH8JNI1C5vNR0yfXtKhvWBmsrPEcLvn72O34V7ZY+cNd1X/VlSIivJz0PWi4+3DTUw0HneYuDzj71Jq6N/apTWn8vXyPO/g/4YbwPoFtp2pWdxe6lK0k1xcGMNliQAMnnAUCn/ABC8F6R40sZZZbG/sNTspy8N/aRqkygAZXd3B969LcXP2yH54guxtwweeR0qALcfZdRAePJZ9pweOO9FiFWi2nbt1fc8Ls/h94u01NNl0HxprKW0pTKXtpHceX8vBXdx+gqa98P/ABdlvYJV8RW/2m1K7QlgiJOueTJjv7DivbNPW4/snS90ke7bHu+Xtt7Vo4l88ncvlbeBjnNJRCriUpNcqe/V9zw+w+HF1rOy/wDiTeXviEW6sIbBbZLeCJ2PLYQgsfQmu+sNH0TQdS02DR/DMVpGIpMeTbIp/g5J6k+5NdZKk/2OQeYhlzw23jrVa6Wb+27DbIu3y5dwK9fuUWsKNZSk3b+bq+xi6vomia+LyHWPDcN4hAGZrdGYfL2PUH3FeZv8EtAWyhfTbnxbpw+QtFb3gCkg8Ngg9M17jCsonudzrgkbfl6cUxFuPskX75A2Fydn0qrXM41lF6eXV9jxyT4aaxbagk2jeMPF8F1GAVkunjuExnoUOAfxqhF4B8WalDcSaj421/yo53BjtLaK33/NySV/wr3fZP55bzV8vbjbs5z9c1Qs1uPsd1mVN3nSY+Tp8xqeVGkcQnHZdO55VcfCt3Nuknijx46OSGBv06bT/s8VHa/CRImntoPEnjpIAoAX7enQjoTivZpEm8yD96oAb5vl68GlRZfPmO9QvGPl9qfKiPrOmy28+55H4b+G+heEI31G2stW1C+dkRZdQlWYxDfzs6bc969PkvJDPEG0u4JII3fLgD060mpJcDSyGkTf5i87P9sVfdJ/NQrKoQA7hs6n86drDnVjKKulu+r8jx2++Gt9Ya1qmq+BdS1Hw0b0N9pto7eKeKZuTkK5wvXtWp8JNI8Q6FpE114utpbzXL26zJKoQfu1BCcDAHFemqlwFfdOpJzt+TGP1prpc4hAnTdu+Y7OvHbmlYj26as0vxMzS1X7PqAW8OTO/wA24cVekC77XN3gg/3h83yms7Szbta6j/oh2id8jyutXZRbiS0BtCeeP3XT5TVIqqvff/A7HgP7TFrbzeMvAzSMjl9RWNi204X5ePpUv7SFlaSP8Pg0iSbtZ8kk7T8hccfT9Kh/aVkjfxf4QW3sbqX7JepcXBhtmYLH8vXA9ulM/aD1OymXwM9nZXDx2+pC9mKWjYEO8deP0qO5rZuKt5fke+3AiXULALebVAcBQy9NtR24Qy6l/wATEnL8YdePkFRtNZXF5pssdk+2RGdSbfHBX6UWhtDPqX/EvYfvO9v1+Qe1MlJqPXbsv5iIRJ/Z1h/xM3GJE/jXnmnBEHisH7cx/wBE6F1/vGmBrP8AsuwJsGI8xMD7P05+lKGtj4rUCyYf6J1MGP4j7UGuvvb7S6ImEaf2Tej+0HOTJzvXjrVqdENxZYvX4Lc715+WqmbX+yLwiyIH7zjyev6VamNuLmxxaEZLYHldPlpmMr3+/t2FVUN5d/6a3+rXjevH3qz9JVB4btcXzgZHO9f73Sry/Z/tl5i0IxEuf3XX71UNI+zjw1af6GcEj5RFn+KjqUvg+ce3ZmptT+0+bt8+V93cOeTVdIwbLU8XTn55Odw44FWT5P8AaQBtiT5XDeX05qshiFhqhEBxvkyoTr8opmUb/l27kOqRr52ik3bcTjALD5vlNaESoL2cm8Y/Kvy7hx1rP1QRebon+j9Z1x8n3flNaEYtzezr9l+YKuW8vr1o6lTfuL0fb+YoCNTotsBfMcMnzb19aszKh1e2/wBMYEQy8bl9UqsnkLotsRZnG5Pl8r3qzKIP7Yth9m58mXnyvdKQ38T/AO3u3YoaUibNYU3zDNw/zb144q6yI0em4vGGMfxD5vlqlpX2fZrLfYzxcP8AL5XXirgEIh00m1PO3pH935aFsXVvzv8A4H8pPCE/tO5/0pi2xPl3Dj71ZOrIn/CJXG66cr67h/fFa0JhOqXS/ZiCI0y/l9evFZGsmP8A4Q65ItTn+7s/2xzSlsKhf2kPWPY2p1X7dbf6Q2cNhcjnimRiP7Rf/wClNyV3fMPl+WlnMf8AaFn+4PIfnZ04psXl/atQ/wBGPBXnYPm+WqOdfD8vLuRlY/sVmFvH2+YuG3DnrxTVCf8ACTN+/bf9m+7kf3qkV1FlaEWbHLL8uwcdeajVgfFJXyD/AMe338D+9SZor+96PsTbUGnXX+kMV3yZbI+X5jxUkqr5un5mYnedvI+b921MDD7BdYgPDycYHzfMeafO2JdN/ddXPYfJ+7agz1u/n+Q6JVF9ckSsTsXIz0rM0d4x4aib7QVUO/z56/vGrUjP+nXP7o/cXnA+brWXobAeFom8jf8AM/yYH/PRqOpcfg+cfyZpOV/tODM5BMbYTP3veoQqeTqWJixJbcCfu/LVpm/06EGA8oTv4+X2qEn/AEfUT5OMFv8Agfy0zOL2+X5lDVhGbTSMXDbRcRYIb71XwE/tuXLtv+zp8ue25uapatIVs9KIt2/4+Ivl44q6jt/bUg8o/wDHunzcf3m4qTWV/Z/f27or/uV0m/xM2zMgLE9OKuzFPMtf3hzu+UZ+9xVRmb+ytQJgIP7z5OOeKvSyFfI/clixx2+XimjOe/zfbsjPsJIv7c1YCUl8Rbh6fKabMtrJpkYNzJ5fmL8249d1GmyE67q48hgQIucjn5TUwlZdPiItH++PkyP71CNJaTVv7vVdh8gt/t8JaVw4RsDceeRUHmWxt9Q/et9593zHjirrSSfbY/8AR2I2N82RxyPeqxmkFtf4tm4Z/wCJeeOvWhkRvZfLqu5HYvbnStMzIQMR45PJ21eBg+2Nh283ZyuTjFUrOaQaVpeLdjlYx1HHy9etXzJJ5x/0dsbfvZH5daFsKr8T+fVdyrI1q1lIBMxj3ctubg5qC9e3GuacXkYHy5cfMefuVdkkk+ysRasDn7uV9frVa6kl/tqxxbsR5cueV4+570MdPf8A8C6rsSxPb+fdHzG6jdyeOKjEtn/Z8O6VggCYO5varEMspnuM27DBGDuXnj601JZfsUR+zHOF+Xcvt70yf+B1XYcHtftRYSN5u3pubpWdYNaCzvcTNt8+TcdzcfNWr50vmlfsz4xnduX8utUdPllNtdf6K2fPk+XcvPzfWkVD4X8uqLDyWxa3/eN975OTz8ppEa2+0zfvG3cZG5uOKklll82D/R25Y5O4cfKfeljll8+UG3bbxg7hzx9aZn0+XddzJ1T7GdH4lfb5q4O5v+elaTvaGeEmR9+DtG5ueKq6pLIdKYm2YHzF43L/AHx71feWXzYgLdiDnJ3Djj60dTWT91er6rsiNRakTAO/zZ3fM1Ru1pstx5j7Q2F+ZueKsmWXY+bdsjOBuHP61GZpiISbVwS3I3LxwfegyTf9NGNpi6yYb4IdPDGd8ZD9atyf22Hth/xLs554f0NM0xIPJv8A/TGCmd8t5g4q3KIQ9sDesOeP3i88Gix1VJ++9F93kVYl1k3dz/yDcfL1D+lZWpjWT4eO8aaR5qcAP/z1Fb0Ih+13RF6wY7cjzBxx1rG1Rbf/AIRsg6g2BKnPmr/z2FS1ozShP95HRbx6Fy4Gt/2hZ5Om/wAfZ/T60lv/AG6Zb75tNzv/ALr/ANxcd6muBB/aVkRfsSA/Hmr/AHaS2EHnaj/p7n5xn96OPkFFiOb3dlt2/vFBF106fYfvdOH7xc/I/PP1p7DWP+EnT95YA/Zem1v731qWMWv9macDfMFEi7T5g55p+YB4tT/SSXNpwN4/vGixrzu8vdW0ugwJrI0263zWP/LTGEbpzU08esm4sv39luDNn5G5+X60Frb+yL7bduVzIGO/oasz+R9o08GZjydh3dflosYubv8ACuvTyKix6z9uu/39ljy0x+7b/a96p6RHq58PWpjntByDyh6bq10aEX97++bPlJu+bp96qGkC3/4Re1zMwjyMNk9d1FlcpVHyfCt49PJl3Zqf2/Pm2m3yxkbGz1+tVI01P7HqQ861yXkx8h44Fah8saquXbzPK4XJ5GaqoY1sdWIc48yTcc9DtFBlGb7Lp08ylqcWpFtIbzrUbZ13fKeTtNXoRqn2yYNJabcL0Rs96j1PyidGJkYEXC7Bn73ymtBDEL6bDnzNq7lz064phOo+RaLZ9PMyPL1X+x4FEtp5mU52N0zU0qan/a1qfNtAPJkz8h9U96WM240OEiZvJ3L85JzndVucp/bNoC5DeTIQM8HlKVhub5novtdPIydOh1MHVQk1qCZ2Iyh9Ksxx6qbay23FqGwMnyzyMVDppgZNaBmfHnvuOTxxVuAW5tNMPmuQgXYeeflprYurJqT0/DyCOLU/t8x+0223YnHlnOeax9Yi1X/hFrjNzb9P+eZ6bxXRQyRHUrgAt5hjTI56c1jawYF8I3Q3NsHU/N13ilJaBQm/aR0W8eiLk8Wq/bLbF1bAYbP7s+lJFDqpnvf9Lt8krt/ddPlq5cPEb+0JLbsNgYPPFIhtxNfZZ+SN/wB7j5aLGSqS5fhW3ZdyiIdXFnbAXluH3KCfK7VEItT/AOEiIF5Bt+z5I8r/AGqtn7GLK1BZzGHXafm5NRn7OfEpyX3i26fN/eoaNYzfve70f2UCwamLG4zew53vj910G40s8Gpmaw/02LHmHP7of3GqVWtRYXIBfbvfd97+8aLhrbztP5f752/e6eW1OxHPK707/ZXYakGo/bJx9ujxsXH7oVmaPBqX/CNx7L2IPuf/AJZDH+sNbELWpvrjBfdsXPDdKytGNmvhqMSNIE3Pz8//AD0al1NIylybdY/ZXZmi8Gp/bIAL6PZsbcDEOT7VALfUjFf7r+Pb82AIh/d71aka1+2253PnY2B8/Soh9j8i/wBhkyd277/92nYzjJ22/wDJV3KWo22o/Z9N330Zb7RFnEQ/Sri2+of2vJ/pybfIX/lkM/eaq2p/Y/sul5Mm0Txbfv8ANX1Nv/az/f3eQuPvdNzUFynLk27/AGV3RBFFfLYXpnvFcjzOkYx04qWe21Hdb41BfvfNmFeeO1Ru1r/Zd+QXKfvM/e9Ksym0LW+S+d3yff8ASnYzcne9u/2V2MvT7bUf7c1T/iYJjEWMQj0PWrJtNVNmo/tJPN3jnyFx1ptj9l/tzVMF9xEWR83oasgWAtFwZPL3gZy/XNJI0qVJcy06R+yuwNaah9qjI1L5QpyPIXPaqrWeom2v86mOS+P3C+ner7/ZRdJnzN+04+/7VWk+yC2vQ3mfebP3/SixnCctNO32V3Ktlaah/ZemY1LHyx5HkL029K0Daah53/IUITb93yFzmqdk1mNK0zPmYxHj7/XbWgv2Q3JI3+Zt5+/0oS0HVnLmenf7K7laW11I2zH+1AG9fIXHWq9zZ6h/a9jjVD9yXJ8heny1cc2P2WT/AFnl5Ofv+tVrl7MazYD95kpLj7/+zQ0OnKV9u/2V2JYrTUfPnB1Q4yMfuE9KatpqIsov+Jqc4XP7hPapYfsYubr/AFmSRu+/6Ui/YhYQ58zZ8uPv+1FieeV9u32V2FNnqPn5GqkJt+75CZzVKwtNR+z3ZGqnPnvj9wnrWp/opuOkm/b/ALfSqditn9nu22vt85933+eadgjUlyvTt9lD5bPUPMg/4mh4bn9wn9009LS/82TOpHHGP3KelSubZJLf7+d3y/e/umlT7OLib7+7A3fe6YosRzytt0/lXcy9Ts9R/sw/8TQ5Ei5/cpz84q+9pf8AnREamwABBHkpzVPURbJoxwshXzFwPn/56Vpv9nNxDkOXwdv3umKLFynLlWnV/ZXkQra3wWTOpEnnH7leKa9rfbYR/aZzuGT5K88GpwLULPtDgc7+G9KaVtfKtsK+zcNn3uOKLGanLt/5KirpDo0WoZtmAFw/y7fvVbmZA9r/AKMxyf7n3eDVXSFuDFqA8yPzDcPtO3gdPer0izb7cCSPIPzZXrwenNMdVr2j/wCD2IoWT7bdD7O3G35tnXjpWLqrxjwuxFo/+uX5dn/TYVtwrcfbro74tny4G05zj61j6mLoeF2/exbxKnOz/psPepexrQt7SPrHuX7mRf7SscWj9H52Dj5elLbSDztQP2NuHGPlHzfIKdcrc/2hY/vYsfPn5OT8v1otI7vztQ3zoSXGz5OnyCgi65fl5/zFRXxplhmyYnzE4wPl+agO58Wp/oxA+yfe44+Y1LHDc/2bZA3SqwdcnYOeajMVz/wliEzgp9kx9wf3qGapr3ttpdyUM39l3pFoRzJ8vHNWLh3FzYf6MSSW7j5flqARzjTL4m6DElyp2j5frU88cv2iy/0jnLZO0c/LRcxdr9OvfsCPJ9uvP9Hx+7TByPm+9WfpEkv/AAjFqfs2Tx8uR/e61oJHIb67H2k58tMfKvH3vas/S45v+Eatv9Kw3rtXH3qXUtW5em8e/ZmqWcamAISV8r7+Rxz0qsGYWWp/uejycZHPy1Y8uT+0gfPbaIvu4HPNVQr/AGLVMzn78mOBx8tBlG35d+5FqzN5mifuc5uF5yPl+U1oxyOb+YeRgBV+fI+brWbqqyZ0bE5x9pTPA5+U1fiST+0Zz5527FwuBkdaEVNL2a9H37lISSDRIWa1JbcvyZH96rsjv/aduPJyPKkOcjjlKqiOZdHhU3I37l+faMfeqxKj/wBq2379seTJxgc8p7Uwla72+137FHSmk3awBbnJnb+IfNxVqGWYWmn4tichQfmHy/LVbS4pc6uPtPzGdsHA+XjvU0UU5s9PK3ZHCbvlXn5fpSRdSzk9unfsWY5Zvt8y/Zjt2L824c9aytZeU+FbnNv26bh/fFakUcv9oTD7UxGxPl2r789KytYjdfCtzuumYY64UD749qJbBQt7SO28e5r3Ekv2y2xASMNk7hxxRA8purvMGACuPmHzfLROkn222xOwHzcYHPH0oiRzc3YE7Dlew+X5aZhpy9NvPuIHmFrFi1JO4fLvHHNVTJMPEfFtlfs33tw/vVZMcptYcXjA7hl9q88/Sq4SX/hISv2nj7PnG1c/e+lNmkLe9ts+5Kjz/YZ/9G53yYG8c/MaWaWYS2ObbkyH+McfI1J5cv2G4xdnO58Havy/Mfaknil87T/9KY/vDn5V5/dt7UugtLvbr37EqSTfbpx9n+XYuDuHPWsnSXnbwygS23He/G4f89WrSSOX+0LgfbGHyL8u1eOvtWTo0cv/AAjEZW+KfO/O1cf61vajqawS5Om8e/Zm28k/2uD/AEbja2TuHFRtJL9nvswYxuI+Yc/LRIHF9br9sblG+XC/N79KiKMIb8/bSc7uML8vy/SnoYpLTb8e5Bqks/2bTD9n5+0RZG8VeV5P7Uk/cnHkrzuH95qztUVza6Xi+PNxF82F5/Sr8auuqyBrkn9wvBCg/ebnpSNJpezW3Xv3RG0kx06+zb8/vONw54q1JJPmDFvxu+b5xxxVMhzpl/8A6USR5nzYXjj6VbnV824+0kHd6L83H0pmckr9OvfsUbB5hrmqZtyBiLB3D0NXlkuBAP8ARcMG+7vHrVOwjca5qf8ApRY7YvlwvHDe1W9r/Z/mvTncPnwvr06UDq25lttHv2Q95ZxcIBb5TacneOOlVzJP9mvM256tj5xyMVOyOLmPN0QNp+XC89Paop4pBbXZ+1MMhiOF+Xj6UERtpt+Pcr2kkx0zTP8AR+cR5+ccfLV8yz/aNv2f5Nv3t4rOtFcaTpebsjiPJwvPy9OlX8H7Vxd87PuYXPXr0oVrF1UuZ7de/cb5s5tnJtsNuPG8etVrqSb+2bDFvkbJed44+7UmMWsoN+D8x+f5eOagvP8AkM6eTebfkl4+Xn7tJ2HTS5nt179i/G8vnT/uOMjB3Dnio0eU2MP7n5sJxuHHSkjYCe4zeDqOMr8vFMVlOnw4vVXhPnyvPSndGfL5du/YuF5fNwIspjruHWqFhJOba8LQYYTvtG4c81bDp5+ftg6fcyv51Rs3QW15vvF/1z/Nlfl5ouhwj7r07dzQd5fMh/dcbjn5hxwaVGfz5QY/lGMHPXio5ZYxJBm5QDcerD5vlNJHPF9on/0lM8cbhxxRdEcrtt08+5V1J5jpLHyxv8xcjd28wVoMZDLFhBs53EnkVk6hJENGKm9TiRfm3Lz+8rReeDzoibtBwfl3r81K5pKL5dur7+RPmTbJ8gyM7eetRlptsH7td5YbxngDHao/Pg2zD7ZGc5/jX5eKYJ7cQ26i9jOCPmMi/NxRoZqD7fmY2k2Onm11M5lMYnfcdzcVeuLGw/0EMZQCfkw7c/LTtJeXytQPkDcLh8Lu+90q3K82+0xbqcnn5/u/KaDpq1Z+0er+/wAjOh0/T/t90v7/AHgLkbn6YrG1Ww03/hGHbdNt81Ru3N/z1Ga6mGSf7bdD7ONo24bf1OOlZN+058Mtm3UN5q/Lv6/vhUtaG1CtNVI+8949Rk+maWmp2GBNnD4G5+Rtp9pZ6YZdQAE5AbDDL8DaK0LmWf8AtOxH2Ychznf0OOnSkt5LoXGoH7Kv3xj951+RfanoQ6s3HWT2/mX8xkJp+lrptiTHNgyLgkvzzSSafph8UxoYpc/ZSdv7z+91rRjkuv7Nsv8ARUJ8xcjzOnP0ppkuf+ErXNsuPsnXzP8Aa+lJo0VWpeXvPaX2igNO0n+y74iGUgM+f9ZVmXT9J8+xxby7STjiT+7VsS3X9nXmbVM5kwPM6/pU88t19ps8WyZy2f3nTj6U7Ih1ql/ifX7XkZiabpIvrv8A0eXiNc8Sf7VUdNsdJbw1bsbeRhkc4k67q6JJLn7Zcn7MmdiY/edfve1Z+lS3Q8N2+y2QsRjHmY/i+lFlcqNapy/E94/a8mOax0r+0ADbvu8vj5ZPWqo0/S/sOpn7O+A8mch/7tbRkuftwxbLjy+T5nTn6VV825+xalm2QHdJj95/s/SixnCrU/mfT7XmZeo2Gm50bZA4zcLjh/7prQisdLGoz7YH8zYu7h/ek1KS5xpH+jrzcJu/edPlNXopLk38wa3QKEXB8zr19qaWo51J8i957P7XmYn2DSRo6bYJCm8ZJEmfvValstLXVbYeQ+4xSY+V/VKnE12dJjJtkLbhx5nH3vpVmWSf+1Lb9wuPKkyd/TlPaiwSqzu7yf2vteRhaTYaS8mrBreRlFw2eJOmOlWorDSRY2O+1fBC4+WTjip9GlufO1Um2QYuGx+868D2qzHJcG0sStsh4TOZMY+X6UJKxVWrU537z6fa8ipDp2ktfTBbV94RckrJ05rL1fTtKHhe6aO2cDHPD/3hXTpJcfapc26hdq4PmfX2rM1l5v8AhGLkvCobHTfn+IUmlYVGtU9pH3nvH7QsumaULy3T7M24hscP6UR6XpQnus2zdRnh/StKZpftlv8AuhjDfxe1JFLP59yPJXgjHz9ePpVWRj7apb4nt/N5maNO0c2kRNq+wkYGJOuarHTdKHiLYbZt32fPR/WtoSTm1iYW6bty5Xf05qvvnHiDAhXabfk7+fvUNFwrVPe957P7RTOnaT9jnP2VsBnz8sn940XGn6X5un4tnwZDj5ZOmxq1S8xs5SIl3ZfALcdTTZnn8yy/crnec/P0+RqVkSq07v3n1+15GamnaT9uuAbV9wRSflfpzWZotlpbeF42ktWILPxtf/nocV00TTfb5/3S7di4O/61maI8/wDwja7YVJ3Scb/+mjUrK5tGtPk+J7x+15Me9hpY1C2AtW3bG2na/Apq6fpnkX+y16bs/K3Py1pymf7dbnyk2bWz83INNLTGG9zEgxu24br8veqsYKrOy95/f5mLqdjpq2umEWhAM8QA2tkCtBdPsW1R82/PkryQ395qTVTP9m03Eab/ALRFuG7gVfUv/acg2jHkrznvuapsVOrPkXvPr180ZLWOnDTL8i2IUeZkYb0q1cWGn7rTdbE5b5DhuOKlcynTr75F3/vMDPtVmcy7rfCL9/5uenFUTKrO/wAT69fIxrCxsDrupqIDuCxZOG9Gq0+n6WLXm1Plbh8uG65p9g0h13VAyKFCxYOeTw1Wy1z9mBEUfm7vu7uMZo0HVqz517z2j18kVnsNPa4jVrYlsHBw2B0qA2Vh9nvcW5GCwbhueK1SZPPTCLs2nJzzmoJPNFvd5Rf4tuD1GO9BlGrP+Z/f5mXaWNgdK00/ZsqRHxhuu2ro0+wF3gWuH2Z3YPTNFp5h0vTPlXdiPcM9Plq7mT7Vgqvl7eDnnOaSLqVZ3fvPr18zNNhpptJCbL5NxypQ8nNV76wsF1nTQ1qDlJcYUnH3a2AZzbvlY/NycDPHWoLnf/a9jhV27JNxJ5H3elDCnWnzP3n16+RBFYWHn3P+iDIIydp54pqWGnnToD9kXYdmF2njpWjH5nn3GQuzjb69O9NjEosodoXfhcjt2zTI9rP+Z9OvkQnT7L7SP9ETft+/t4+lUbG1sza3260BQTyAgr157VtfP5v8Pl4/HNUdO84QXZYR7/Pk24zjr3pDhUlyvXt1Feys99tm1XJb5cr935T1ojs7M3U+LVN3y5YqMHirb790P3fvfN+R6UIH86XO3bxj16UGftJW36d/Mw9StbNNFObJSvmqAoQcfvK0ntLUzw5skLAHDbB8o9Kh1ITnSm2+UG8xcgg4/wBYKvN9o86PBj8vndwc5oNpVJcu/V9X5FZba0xORYgdd37sfN9KY1rZtFb/AOgLtLDC+WPl471cH2n95kw9fkwD+vNNIuCsWWiD5+bg46duaDNTff8AFmfpUcixaj/pEhPnvg4HHH0q28cjfY8XEgIPPA+b5fpRRVJFVJPnb/rYIYZPtdyftEm07cDA44+lZGrwTJ4acC6k3CROcD/nqPaiioezLoTftY+sTQuLeX+0bH/S5cYcEYXnj6U63t5vOvh9rl5cYOF4+Qe1FFCM+d8vy7L+YrJbzDTrMfbJs+YuThefm+lRNBL/AMJYg+1S4+yZ6L/e+lFFN9DaM3eXpLoiwbeVdMvAbuYnMhzhf8KsTW0v2i0/0qbIJycLzx9KKKDJ1Hf7+i7Cpby/bbk/apeY0xwvH3vas3SLeVvDNti6lBxnOB/e+lFFLqXGb5H6x6eTNMwy/bxi5lx5fIwvPP0qqYZPsGpA3MnLSc4Xj5fpRRTZEJvT5fmQ6nBJnRv9Jl4uEzwOflPtV9LeT+0Jm+1S4KLxheOvtRRQipzfIvR/mU4reVtFiBupclgd2Bn730q1NDJ/a9qftEuBDLxgc8p7UUUClN8z/wC3vyK2kQP5uqj7RLlp2weOOB7VatreR7Gy/wBJlBVVJIA54+lFFCFWm+Z/L8idY3+1ynz5MbVwMDjr7Vla3C//AAjV0pnkJI68cfMPaiiiWw6En7SPrE05o3+2W3758fN6c8fSkihb7RdnzpPmK46cfL9KKKZlzPl+X6iLA4s4l8+XIK/Nxk8/SoDC/wDwkIfz5MfZ8beMdfpRRQVGbvL5k4hb7JOvnyfMznPHHJ6cUlxG4m0/98/Ehz05/dt7UUUhKTu/n+QsUTf2lct50mCijHGB+lZejwsfCyoJpAQ8nzDGf9a1FFLqbRk+T5x/JmtJE3262bzX+VW44waYIysWoHzHO4see3y9qKKoxUnp/XUr6kha100F2yJ4ue5q4q/8TSRsn/UqMdvvNRRSLk/c+/8ANEMiEadfje2T5hz6cVZnXL253MMP+fFFFMzb1+/8inYpt13U23MdyxcHoOGq75JNv5fmSA5+8Dz1oopDrSfMvSP5IlZcyK2TwDx+VV5UxbXeGb5gx+nHaiigzi9StZxn+ytNXe3AjOe5+WruzF3v3NymMdutFFC2LqN8z+ZG8GbWSPzJPmJO7PI5qvdRk6vpx3thEl4z977vWiihjpyfN8n+RZjj/f3JLP8AMR36cdqasI+wwpvf5QnIbk9KKKaJ5nf7icxjzQ25umMZ4rP0+BRbXi7nw0787uRz2oopLccJPlfyLskQLwnc/wAp/vHng9aSKIC5mO5+dvG4+lFFBHM7f13M/VLZW0hl3yDEinIc5/1grQeBTNE26T5QRjccHiiin1NZSfKter/QcYFw/wA0nzf7Z4qJrVDHAu+XCHP3zk8d6KKDJTl3P//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27926=[""].join("\n");
var outline_f27_17_27926=null;
var title_f27_17_27927="MCL pathogenesis";
var content_f27_17_27927=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F73115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F73115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 538px\">",
"   <div class=\"ttl\">",
"    Overview of mechanisms in the pathogenesis of mantle cell lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 518px; height: 721px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Most cases of mantle cell lymphoma (MCL) are postulated to derive from na&iuml;ve pre-germinal center B cells of the mantle zone. In the vast majority of cases, expression of the cyclin D1 gene, located at 11q13, drives cell cycle progression from G1 to S phase. A minority of cases do not demonstrate cyclin D1, but are thought to overexpress other cell cycle mediators, such as cyclin D2 and cyclin D3. In addition to cyclin D1 expression, MCL tumors demonstrate a decreased response to DNA damage and enhanced cell survival (impaired apoptosis).",
"    <div class=\"footnotes\">",
"     ATM: ataxia telangiectasia mutated gene; cdk: cyclin dependent kinase; CHK: cell cycle checkpoint kinase.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27927=[""].join("\n");
var outline_f27_17_27927=null;
var title_f27_17_27928="Use of combination estrogen-progestin contraceptives in the treatment of hyperandrogenism and hirsutism";
var content_f27_17_27928=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Use of combination estrogen-progestin contraceptives in the treatment of hyperandrogenism and hirsutism",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/17/27928/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27928/contributors\">",
"     Ricardo Azziz, MD, MBA, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/17/27928/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27928/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27928/contributors\">",
"     William F Crowley, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/17/27928/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27928/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/17/27928/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common clinical manifestation of androgen excess in women is hirsutism, followed by ovulatory and menstrual irregularity, acne and alopecia. The most common cause of androgen excess is the polycystic ovary syndrome (PCOS). Other much less common causes include non-classic adrenal hyperplasia, androgenic drugs, and ovarian and adrenal tumors. Idiopathic hirsutism is not strictly an androgen excess disorder, although it is the cause of excess male-like hair growth in 5 to 15 percent of hirsute patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/28/24007?source=see_link\">",
"     \"Pathogenesis and causes of hirsutism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=see_link\">",
"     \"Evaluation of premenopausal women with hirsutism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of hyperandrogenism depends upon the desired goal. For women who want to become pregnant, the goal is to promote ovulation with either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    (with or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    ) or gonadotropins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/49/1817?source=see_link\">",
"     \"Treatment of polycystic ovary syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If fertility is not desired, treatment varies with the main complaint:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For women whose predominant complaint is hirsutism, treatment may consist of cosmetic therapies, ovarian androgen suppression, generally with an oral contraceptive, alone or in combination with an antiandrogen (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link\">",
"       \"Treatment of hirsutism\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For women whose predominant complaint is oligomenorrhea or amenorrhea, therapy should consist of an oral contraceptive or cyclic",
"      <span class=\"nowrap\">",
"       progestin/progesterone",
"      </span>",
"      withdrawal, although",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      alone may be helpful in some patients. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=see_link\">",
"       \"Metformin for treatment of the polycystic ovary syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/49/1817?source=see_link\">",
"       \"Treatment of polycystic ovary syndrome in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review the efficacy of oral contraceptive therapy in women with hyperandrogenism and hirsutism. Among the treatments listed above, this is the best studied, most widely used, simplest, safest, and least expensive modality. The different types and properties of oral contraceptives are reviewed separately. In addition, the Endocrine Society's Clinical Guidelines for the Evaluation and Treatment of Hirsutism are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=see_link\">",
"     \"Overview of the use of estrogen-progestin contraceptives\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link\">",
"     \"Treatment of hirsutism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MECHANISM OF ACTION IN HYPERANDROGENISM/HIRSUTISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The key pathophysiological abnormality in women with PCOS is increased ovarian secretion of androgens. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/0/12?source=see_link\">",
"     \"Steroid hormone metabolism in polycystic ovary syndrome\"",
"    </a>",
"    .) Likewise, many women with nonclassic adrenal hyperplasia may also have an ovarian component to their hyperandrogenism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=see_link\">",
"     \"Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Testosterone is the major androgen secreted in a process that is largely luteinizing hormone (LH)- and insulin-dependent. Oral contraceptive therapy reduces hyperandrogenism by the following mechanisms:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inhibition of ovarian androgen production through suppression of LH secretion",
"     </li>",
"     <li>",
"      Stimulation of the hepatic production of sex hormone binding globulin (SHGB), thereby increasing androgen binding in serum and reducing serum free androgen concentrations",
"     </li>",
"     <li>",
"      A slight reduction in adrenal androgen secretion",
"     </li>",
"     <li>",
"      A modest inhibition in the binding of androgens to their receptor",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Inhibition of gonadotropin secretion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral contraceptive therapy decreases LH and to a lesser extent follicle-stimulating hormone (FSH) secretion in hyperandrogenic women [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. In studies of gonadotropin secretion in women with PCOS, serum FSH concentrations fell more rapidly than did serum LH concentrations, but the fall in serum LH was greater (70 versus 50 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The result was decreased ovarian secretion of testosterone and other androgens by the ovaries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Increased serum androgen binding",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the circulation, testosterone (and estradiol) are bound with high affinity to SHBG and, with lesser affinity but greater extent, to albumin. In women, only about 1.0 to 1.5 percent of the testosterone in serum is in the physiologically active free form [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Androgens and insulin both decrease the hepatic production of SHBG. Since both are often increased in hyperandrogenic women, these women have lower serum SHBG concentrations than normal [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Estrogen (and oral contraceptives) causes a dose-dependent increase in serum SHBG concentrations over three to four weeks in hyperandrogenic women [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/4,9,10\">",
"     4,9,10",
"    </a>",
"    ]. This increase is smaller in women treated with an oral contraceptive containing a progestin that has significant androgenic properties (eg, norgestrel) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/11\">",
"     11",
"    </a>",
"    ]. As serum SHBG concentrations increase, serum free testosterone concentration decreases. This may be due to the fact that estrogen inhibits LH secretion, preventing a compensatory response to the fall in serum free testosterone.",
"   </p>",
"   <p>",
"    When hormonally evaluating women who have been on an oral contraceptive, it is best to discontinue the medications for at least 8 if not 12 weeks, as it takes at least this length of time for measured androgens and sex hormone-binding globulin levels to return to basal values [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Reduction in serum androgen concentrations",
"    </span>",
"    &nbsp;&mdash;&nbsp;As a result of both inhibition of LH secretion and increase in SHBG production, serum free testosterone concentrations decrease by approximately 50 percent in hyperandrogenic women treated with an oral contraceptive (",
"    <a class=\"graphic graphic_figure graphicRef61395 \" href=\"UTD.htm?42/56/43918\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/1-3,13,14\">",
"     1-3,13,14",
"    </a>",
"    ]. Serum total testosterone concentrations also fall, but not as much as free testosterone, because of the increase in serum SHBG concentrations. These changes may occur over several weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/1-3\">",
"     1-3",
"    </a>",
"    ], but can be slower, especially in women with marked insulin resistance in whom both ovarian androgen and hepatic SHBG production are presumably more dependent on insulin than LH or estrogen. The changes are independent of ovarian histology [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Secondary mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral contraceptives may also ameliorate hyperandrogenism by decreasing adrenal androgen secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/15-18\">",
"     15-18",
"    </a>",
"    ], inhibiting the peripheral conversion of testosterone to dihydrotestosterone, and inhibiting the binding of dihydrotestosterone to androgen receptors. However, the evidence that oral contraceptives have any of these actions is not strong, and it is unlikely that these mechanisms contribute importantly to their benefit in hyperandrogenic women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ESTROGEN-PROGESTIN CONTRACEPTIVE PREPARATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Oral contraceptives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Current oral contraceptives are a combination of a synthetic orally active estrogen and a progestin (",
"    <a class=\"graphic graphic_table graphicRef69223 \" href=\"UTD.htm?10/59/11184\">",
"     table 1",
"    </a>",
"    ). Most are administered cyclically for 21 days followed by 7 days of rest, at which time withdrawal bleeding occurs. The estrogen is usually ethinyl estradiol (in a dose of 20 to 35",
"    <span class=\"nowrap\">",
"     mcg/day),",
"    </span>",
"    but some contain mestranol (up to 50",
"    <span class=\"nowrap\">",
"     mcg/day),",
"    </span>",
"    which is slightly less potent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=see_link\">",
"     \"Overview of the use of estrogen-progestin contraceptives\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The progestins in oral contraceptives include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone acetate",
"    </a>",
"    , norethisterone, norethynodrel, ethynodiol diacetate, norgestrel, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    . Examples of newer progestins, derivatives of levonorgestrel, include desogestrel, gestodene, and norgestimate. These latter preparations may have less androgenic activity than other progestins but may be more likely to cause thromboembolism [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=see_link\">",
"     \"Risks and side effects associated with estrogen-progestin contraceptives\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another available progestin is drospirenone, a derivative of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    , which has both antimineralocorticoid and antiandrogenic properties [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. However, the currently available oral contraceptive only contains 3 mg of drospirenone, far too small a dose to exert significant antiandrogenic action in hirsute women above and beyond that of other oral contraceptives [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/22\">",
"     22",
"    </a>",
"    ]. In addition, there are concerns that oral contraceptives containing drospirenone may be associated with a higher risk of venous thromboembolism than oral preparations containing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=see_link&amp;anchor=H28#H28\">",
"     \"Overview of the use of estrogen-progestin contraceptives\", section on 'Antiandrogenic progestins'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=see_link&amp;anchor=H334461099#H334461099\">",
"     \"Risks and side effects associated with estrogen-progestin contraceptives\", section on 'Antiandrogens'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Contraceptive patch and vaginal ring",
"    </span>",
"    &nbsp;&mdash;&nbsp;A transdermal contraceptive patch (Ortho Evra) could also be used, although it has not been studied specifically for hyperandrogenism and hirsutism. Ortho Evra patches deliver 20 mcg of ethinyl estradiol and 150 mcg of norelgestromin daily. However, the average ethinyl estradiol concentration in patch users is 60 percent higher than in women who use a 35 mcg ethinyl estradiol pill (although peak ethinyl estradiol concentrations are 25 percent lower than in pill users). Treatment with the patch increases SHBG more than that observed in pill users, but the reduction in androgen levels is comparable to that with OCs [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/23\">",
"     23",
"    </a>",
"    ]. In one study, the mean increase in SHBG from baseline after three cycles of treatment with the patch or pill was 449 and 274 percent, respectively; free testosterone fell 60 and 59 percent, respectively, and DHEAS fell 26 and 32 percent, respectively. Thus, the patch may be useful in treatment of disorders associated with androgen excess. However there are concerns about a possible excess risk of venous thromboembolism with the patch when compared with oral preparations containing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41127?source=see_link&amp;anchor=H187360456#H187360456\">",
"     \"Transdermal contraceptive patch\", section on 'Thrombosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The combined hormonal contraceptive vaginal ring made of ethylene-vinyl-acetate copolymer, releasing 120 mcg",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/1/35863?source=see_link\">",
"     etonogestrel",
"    </a>",
"    and 15 mcg ethinylestradiol per day (NuvaRing&reg;), is another possible therapeutic agent, although data on its effects on androgens are limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     EFFICACY OF ORAL CONTRACEPTIVE THERAPY IN HYPERANDROGENISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to regularization of vaginal bleeding, the decrease in circulating free androgens may also result in an improvement in the hirsutism and acne associated with PCOS. The reported subjective improvement in hirsutism with oral contraceptive therapy ranges from 60 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/1-4,24\">",
"     1-4,24",
"    </a>",
"    ]. A number of studies have also documented improvement in hair growth using objective measures (",
"    <a class=\"graphic graphic_figure graphicRef82541 \" href=\"UTD.htm?24/25/24991\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/4,10,24-27\">",
"     4,10,24-27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The principal effect of oral contraceptive therapy on hair growth is to reduce or even stop the development of new terminal hairs. In addition, excess terminal hairs present at the beginning of therapy may become finer and grow at a slightly slower rate, and some hairs that are in the process of terminalization (ie, the process of converting from vellus to terminal hairs) may revert, resulting in a reduction in overall excess hair growth. Of note, fully terminalized hairs generally do not disappear.",
"   </p>",
"   <p>",
"    Hormonal treatment must be given for at least six months (the life span of existing hair follicles) before its efficacy can be adequately assessed. Destruction of the remaining offending hair follicles by either electrolysis or possibly lasers is necessary to assure their permanent removal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link\">",
"     \"Treatment of hirsutism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/9/37014?source=see_link\">",
"     \"Removal of unwanted hair\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of oral contraceptives on hair growth is mediated by their suppression effect on free androgen levels (see below). In fact, oral contraceptive therapy can reduce ovarian androgen production even in the face of severe insulin resistance. As an example, four of five women with the hyperandrogenic-insulin resistant-acanthosis nigricans (HAIR-AN) syndrome experienced a decrease in serum androgen concentrations to normal following treatment with an oral contraceptive (35 mcg ethinyl",
"    <span class=\"nowrap\">",
"     estradiol/1",
"    </span>",
"    mg ethynodiol diacetate) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to slowing hair growth, oral contraceptives can also improve acne and seborrhea. In a prospective study of 30 women with acne, as an example, treatment with a biphasic oral contraceptive containing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/18/39209?source=see_link\">",
"     ethinyl estradiol-desogestrel",
"    </a>",
"    resulted in disappearance of acne in 77 percent after nine months of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/29\">",
"     29",
"    </a>",
"    ]. Other studies using different oral contraceptive preparations confirmed this beneficial effect [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ORAL CONTRACEPTIVE THERAPY AND INSULIN RESISTANCE IN PCOS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the usual risks of oral contraceptive therapy, including small increases in the risk of thromboembolic complications (deep vein thrombosis, myocardial infarction, and stroke) and breast cancer, some studies suggest patients with PCOS may also experience a modest, albeit measurable worsening of their insulin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/31-34\">",
"     31-34",
"    </a>",
"    ]. However, other trials have not observed a significant change in glucose or insulin homeostasis in PCOS with oral contraceptive therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/35-40\">",
"     35-40",
"    </a>",
"    ]. Thus, the actual effect of oral contraceptives on insulin action in PCOS remains to be determined. One potential strategy to offset worsening insulin resistance is to combine OCs with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ALTERNATIVES TO ORAL CONTRACEPTIVE THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy with an insulin sensitizer or a gonadotropin-releasing hormone (GnRH) agonist can also be beneficial in women with hyperandrogenism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     GnRH agonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;GnRH agonist administration decreases gonadotropin and therefore androgen (and estrogen) secretion in hyperandrogenic women. Concurrent estrogen replacement is necessary because of the decrease in estrogen secretion with consequent menopausal symptoms and loss of bone, even in women treated for just six months [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/42\">",
"     42",
"    </a>",
"    ]. In two studies in which oral contraceptive and GnRH agonist plus estrogen therapy were compared, the latter proved more effective at decreasing hirsutism [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32005?source=see_link\">",
"     \"Use of GnRH agonists in the treatment of hyperandrogenism and hirsutism\"",
"    </a>",
"    .) However, GnRH agonist therapy in the treatment of hyperandrogenic patients is usually reserved for patients who do not respond well to oral contraceptives, such as women with androgen excess and severe insulin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Insulin sensitizers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 60 percent of patients with PCOS have insulin resistance and hyperinsulinemia. Insulin excess stimulates, in conjunction with LH, androgen secretion by the ovaries. The use of insulin sensitizers, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    or a thiazolidinedione (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/28/43463?source=see_link\">",
"     pioglitazone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2472?source=see_link\">",
"     rosiglitazone",
"    </a>",
"    ) has been associated with decreases in circulating insulin and androgen levels in PCOS [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Although some studies suggest that these drugs may modestly improve hirsutism [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/46,47\">",
"     46,47",
"    </a>",
"    ], it is unlikely that they are more effective at improving hyperandrogenemia than oral contraceptives [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/48\">",
"     48",
"    </a>",
"    ]. A meta-analysis performed as part of the Endocrine Society's Clinical Guidelines for the Evaluation and Treatment of Hirsutism in Premenopausal Women concluded that imprecise evidence of low quality suggests that insulin sensitizers provide limited or no important benefit for hirsutism [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link\">",
"     \"Treatment of hirsutism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=see_link\">",
"     \"Metformin for treatment of the polycystic ovary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Antiandrogen therapy: combination with oral contraceptives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiandrogens are drugs that inhibit androgen action and include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/23/4470?source=see_link\">",
"     flutamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14374?source=see_link\">",
"     cyproterone acetate",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/24/39301?source=see_link\">",
"     finasteride",
"    </a>",
"    . These drugs competitively inhibit androgen binding to its receptor and translocation of the hormone-receptor complex into the nucleus, and decrease androgen steroidogenesis or, as in the case of finasteride, inhibit 5-alpha reductase activity and the local production of the potent androgen dihydrotestosterone.",
"   </p>",
"   <p>",
"    The combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    and an oral contraceptive has proven effective in women with hirsutism [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. In a meta-analysis performed as part of the Endocrine Society's Clinical Guidelines for the Evaluation and Treatment of Hirsutism in Premenopausal Women, the addition of an antiandrogen (spironolactone or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/24/39301?source=see_link\">",
"     finasteride",
"    </a>",
"    ) to an oral contraceptive was slightly more effective than an OC alone (mean difference in hirsutism score -1.7) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link\">",
"     \"Treatment of hirsutism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a study of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/23/4470?source=see_link\">",
"     flutamide",
"    </a>",
"    with or without an oral contraceptive, the two regimens were similarly effective in decreasing hair growth [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27928/abstract/54\">",
"     54",
"    </a>",
"    ]. These women had normal serum androgen concentrations, and it is likely that the combination would be more effective in those with high serum androgen concentrations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest oral contraceptive therapy for most women with hyperandrogenism who are not seeking fertility, especially if they have concurrent menstrual disturbances (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). It reliably reduces serum androgen concentrations and induces cyclic menstrual bleeding. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Efficacy of oral contraceptive therapy in hyperandrogenism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although we do not suggest one particular OC over another, it is reasonable to avoid preparations with the most androgenic progestin,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"       levonorgestrel",
"      </a>",
"      , which has less desirable metabolic effects. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link&amp;anchor=H6#H6\">",
"       \"Treatment of hirsutism\", section on 'Pharmacologic management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      While the effect of oral contraceptives on acne and menstrual dysfunction is evident in a short period of time (one to three months), the effect on hair growth may become evident only in several (&gt;6) months. Treatment should be continued for at least two years before deciding on whether to adjust downward the dose of medications used, although most women require indefinite therapy.",
"     </li>",
"     <li>",
"      The biochemical goal of oral contraceptive therapy is a reduction in serum free testosterone concentrations. Some clinicians measure serum free testosterone after four to six months of therapy, although in practice this rarely provides clinically valuable information, above and beyond assessing the clinical improvement in hirsutism. The serum total testosterone concentration generally falls less than the levels of free testosterone because of the increase in serum SHBG concentration.",
"     </li>",
"     <li>",
"      Women with hyperandrogenism are at the usual risk for the side effects associated with oral contraceptive therapy, such as breakthrough bleeding, nausea, headaches, chloasma, and rarely, a rise in blood pressure. However, women with PCOS may be at slightly increased risk for worsening in glucose tolerance, although the degree of this risk remains unclear. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=see_link&amp;anchor=H14#H14\">",
"       \"Clinical manifestations of polycystic ovary syndrome in adults\", section on 'Obesity and insulin resistance'",
"      </a>",
"      .) It is therefore reasonable to measure a fasting blood glucose, or preferably a glucose level following an oral glucose challenge in hyperandrogenic women before beginning oral contraceptive therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/49/1817?source=see_link\">",
"       \"Treatment of polycystic ovary syndrome in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Oral contraceptive therapy increases serum triglyceride and decreases high-density lipoprotein cholesterol concentrations in normal women. Preparations containing ethynodiol diacetate, desogestrel, drospirenone, or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"       norethindrone",
"      </a>",
"      result in the most favorable lipid profiles. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=see_link\">",
"       \"Risks and side effects associated with estrogen-progestin contraceptives\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/1\">",
"      Givens JR, Andersen RN, Wiser WL, Fish SA. Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive. J Clin Endocrinol Metab 1974; 38:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/2\">",
"      Givens JR, Andersen RN, Wiser WL, et al. The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute women. Am J Obstet Gynecol 1976; 124:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/3\">",
"      Raj SG, Raj MH, Talbert LM, et al. Normalization of testosterone levels using a low estrogen-containing oral contraceptive in women with polycystic ovary syndrome. Obstet Gynecol 1982; 60:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/4\">",
"      Dewis P, Petsos P, Newman M, Anderson DC. The treatment of hirsutism with a combination of desogestrel and ethinyl oestradiol. Clin Endocrinol (Oxf) 1985; 22:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/5\">",
"      Vermeulen A, Sto&iuml;ca T, Verdonck L. The apparent free testosterone concentration, an index of androgenicity. J Clin Endocrinol Metab 1971; 33:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/6\">",
"      Pardridge WM, Mietus LJ, Frumar AM, et al. Effects of human serum on transport of testosterone and estradiol into rat brain. Am J Physiol 1980; 239:E103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/7\">",
"      Mathur RS, Moody LO, Landgrebe SC, et al. Sex-hormone-binding globulin in clinically hyperandrogenic women: association of plasma concentrations with body weight. Fertil Steril 1982; 38:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/8\">",
"      Zhang YW, Stern B, Rebar RW. Endocrine comparison of obese menstruating and amenorrheic women. J Clin Endocrinol Metab 1984; 58:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/9\">",
"      Easterling WE Jr, Talbert LM, Potter HD. Serum testosterone levels in the polycystic ovary syndrome. Effect of an estrogen-progestin on protein binding of testosterone. Am J Obstet Gynecol 1974; 120:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/10\">",
"      Cullberg G, Hamberger L, Mattsson LA, et al. Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome. Acta Obstet Gynecol Scand 1985; 64:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/11\">",
"      Bowles SM, Mills RJ. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives. Ann Clin Biochem 1981; 18:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/12\">",
"      S&aacute;nchez LA, P&eacute;rez M, Centeno I, et al. Determining the time androgens and sex hormone-binding globulin take to return to baseline after discontinuation of oral contraceptives in women with polycystic ovary syndrome: a prospective study. Fertil Steril 2007; 87:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/13\">",
"      Casey JH. Chronic treatment regimens for hirsutism in women: effect on blood production rates of testosterone and on hair growth. Clin Endocrinol (Oxf) 1975; 4:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/14\">",
"      Kim MH, Rosenfield RL, Hosseinian AH, Schneir HG. Ovarian hyperandrogenism with normal and abnormal histologic findings of the ovaries. Am J Obstet Gynecol 1979; 134:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/15\">",
"      Fern M, Rose DP, Fern EB. Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstet Gynecol 1978; 51:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/16\">",
"      Wiebe RH, Morris CV. Effect of an oral contraceptive on adrenal and ovarian androgenic steroids. Obstet Gynecol 1984; 63:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/17\">",
"      Wild RA, Umstot ES, Andersen RN, Givens JR. Adrenal function in hirsutism. II. Effect of an oral contraceptive. J Clin Endocrinol Metab 1982; 54:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/18\">",
"      Carr BR, Parker CR Jr, Madden JD, et al. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. J Clin Endocrinol Metab 1979; 49:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/19\">",
"      Darney PD. The androgenicity of progestins. Am J Med 1995; 98:104S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/20\">",
"      Elger W, Beier S, Pollow K, et al. Conception and pharmacodynamic profile of drospirenone. Steroids 2003; 68:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/21\">",
"      Mathur R, Levin O, Azziz R. Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. Ther Clin Risk Manag 2008; 4:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/22\">",
"      van Vloten WA, van Haselen CW, van Zuuren EJ, et al. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis 2002; 69:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/23\">",
"      White T, Jain JK, Stanczyk FZ. Effect of oral versus transdermal steroidal contraceptives on androgenic markers. Am J Obstet Gynecol 2005; 192:2055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/24\">",
"      Guido M, Romualdi D, Giuliani M, et al. Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study. J Clin Endocrinol Metab 2004; 89:2817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/25\">",
"      Casey JH, Burger HG, Kent JR, et al. Treatment of hirsutism by adrenal and ovarian suppression. J Clin Endocrinol Metab 1966; 26:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/26\">",
"      Batukan C, Muderris II. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism. Fertil Steril 2006; 85:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/27\">",
"      Venturoli S, Marescalchi O, Colombo FM, et al. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J Clin Endocrinol Metab 1999; 84:1304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/28\">",
"      Azziz R. The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response. Fertil Steril 1994; 61:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/29\">",
"      Volpe A, Silferi M, Mauri A, et al. Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel. Eur J Obstet Gynecol Reprod Biol 1994; 53:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/30\">",
"      Redmond GP, Olson WH, Lippman JS, et al. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol 1997; 89:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/31\">",
"      Kojima T, Lindheim SR, Duffy DM, et al. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives. Am J Obstet Gynecol 1993; 169:1540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/32\">",
"      Korytkowski MT, Mokan M, Horwitz MJ, Berga SL. Metabolic effects of oral contraceptives in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995; 80:3327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/33\">",
"      Armstrong VL, Wiggam MI, Ennis CN, et al. Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate. QJM 2001; 94:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/34\">",
"      Mastorakos G, Koliopoulos C, Deligeoroglou E, et al. Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Fertil Steril 2006; 85:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/35\">",
"      Nader S, Riad-Gabriel MG, Saad MF. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women. J Clin Endocrinol Metab 1997; 82:3074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/36\">",
"      Cibula D, Fanta M, Vrbikova J, et al. The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients. Hum Reprod 2005; 20:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/37\">",
"      Cibula D, Sindelka G, Hill M, et al. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin. Hum Reprod 2002; 17:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/38\">",
"      Escobar-Morreale HF, Lasunci&oacute;n MA, Sancho J. Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity. Fertil Steril 2000; 74:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/39\">",
"      Cagnacci A, Paoletti AM, Renzi A, et al. Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel. J Clin Endocrinol Metab 2003; 88:3621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/40\">",
"      Morin-Papunen L, Vauhkonen I, Koivunen R, et al. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab 2003; 88:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/41\">",
"      Ib&aacute;&ntilde;ez L, de Zegher F. Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome. Hum Reprod 2003; 18:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/42\">",
"      Falsetti L, Pasinetti E. Treatment of moderate and severe hirsutism by gonadotropin-releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirsutism. Fertil Steril 1994; 61:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/43\">",
"      Azziz R, Ochoa TM, Bradley EL Jr, et al. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. J Clin Endocrinol Metab 1995; 80:3406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/44\">",
"      Elkind-Hirsch KE, Anania C, Mack M, Malinak R. Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism. Fertil Steril 1995; 63:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/45\">",
"      Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998; 338:1876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/46\">",
"      Azziz R, Ehrmann D, Legro RS, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2001; 86:1626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/47\">",
"      Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/48\">",
"      Harborne L, Fleming R, Lyall H, et al. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88:4116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/49\">",
"      Cosma M, Swiglo BA, Flynn DN, et al. Clinical review: Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab 2008; 93:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/50\">",
"      Pittaway DE, Maxson WS, Wentz AC. Spironolactone in combination drug therapy for unresponsive hirsutism. Fertil Steril 1985; 43:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/51\">",
"      Board JA, Rosenberg SM, Smeltzer JS. Spironolactone and estrogen-progestin therapy for hirsutism. South Med J 1987; 80:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/52\">",
"      Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004; 89:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/53\">",
"      Swiglo BA, Cosma M, Flynn DN, et al. Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab 2008; 93:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27928/abstract/54\">",
"      Dodin S, Faure N, C&eacute;drin I, et al. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. Clin Endocrinol (Oxf) 1995; 43:575.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7387 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.167.4.114-B6D75EF485-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27928=[""].join("\n");
var outline_f27_17_27928=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MECHANISM OF ACTION IN HYPERANDROGENISM/HIRSUTISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Inhibition of gonadotropin secretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Increased serum androgen binding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Reduction in serum androgen concentrations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Secondary mechanisms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ESTROGEN-PROGESTIN CONTRACEPTIVE PREPARATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Oral contraceptives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Contraceptive patch and vaginal ring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      EFFICACY OF ORAL CONTRACEPTIVE THERAPY IN HYPERANDROGENISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ORAL CONTRACEPTIVE THERAPY AND INSULIN RESISTANCE IN PCOS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ALTERNATIVES TO ORAL CONTRACEPTIVE THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      GnRH agonists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Insulin sensitizers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Antiandrogen therapy: combination with oral contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7387\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7387|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/56/43918\" title=\"figure 1\">",
"      Oral contraceptive in PCOS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/25/24991\" title=\"figure 2\">",
"      Oral contraceptive therapy in hirsutism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7387|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/59/11184\" title=\"table 1\">",
"      Estrogen and progestin types and doses in hormonal contraceptive",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=related_link\">",
"      Clinical manifestations of polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/31/9721?source=related_link\">",
"      Evaluation of premenopausal women with hirsutism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=related_link\">",
"      Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=related_link\">",
"      Metformin for treatment of the polycystic ovary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=related_link\">",
"      Overview of the use of estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/28/24007?source=related_link\">",
"      Pathogenesis and causes of hirsutism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/9/37014?source=related_link\">",
"      Removal of unwanted hair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=related_link\">",
"      Risks and side effects associated with estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/0/12?source=related_link\">",
"      Steroid hormone metabolism in polycystic ovary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41127?source=related_link\">",
"      Transdermal contraceptive patch",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=related_link\">",
"      Treatment of hirsutism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/49/1817?source=related_link\">",
"      Treatment of polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32005?source=related_link\">",
"      Use of GnRH agonists in the treatment of hyperandrogenism and hirsutism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_17_27929="Syphilis of the placenta";
var content_f27_17_27929=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F59074&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F59074&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Syphilis of the placenta",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 327px; height: 587px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Chronic villitis (B) Onion skin placental villi.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla J Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27929=[""].join("\n");
var outline_f27_17_27929=null;
var title_f27_17_27930="Pathogenesis of atherosclerosis";
var content_f27_17_27930=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis of atherosclerosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/17/27930/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27930/contributors\">",
"     Xue-Qiao Zhao, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/17/27930/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27930/contributors\">",
"     Juan Carlos Kaski, MD, DM, DSc, FRCP, FESC, FACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27930/contributors\">",
"     Peter Libby, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/17/27930/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/17/27930/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/17/27930/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H27901057\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atherosclerosis is a pathologic process that causes disease of the coronary, cerebral, and peripheral arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The basic aspects of the pathogenesis of atherosclerosis will be reviewed here. Forms of accelerated arteriopathies, such as restenosis following percutaneous coronary intervention with stenting and coronary transplant vasculopathy differ in pathogenesis and are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=see_link\">",
"     \"Intracoronary stent restenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/25/44441?source=see_link\">",
"     \"Pathogenesis of and risk factors for cardiac allograft vasculopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901064\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atherosclerosis begins in childhood with the development of fatty streaks (",
"    <a class=\"graphic graphic_table graphicRef56922 \" href=\"UTD.htm?7/18/7468\">",
"     table 1",
"    </a>",
"    ). The advanced lesions of atherosclerosis occur with increasing frequency with aging [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. The following points demonstrate the frequency of atherosclerosis in Western populations and its progression with age:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an autopsy study of 2876 men and women aged 15 to 34 years who died of external causes, all individuals had aortic fatty streaks [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another autopsy study of 760 young (age 15 to 34 years) victims of accidents, suicides, or homicides, advanced coronary atheromata were seen in 2 and 0 percent of men and women aged 15 to 19, and 20 and 8 percent of men and women aged 30 to 34 [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 260 peri-renal aortic patches collected during organ transplantation, the first three decades of life were characterized by intimal thickening and xanthomas. The fourth, fifth, and sixth decades were characterized by more complicated plaques of pathological intimal thickening, early and late fibroatheromas with thin fibrous caps, ruptured plaques, healed rupture, and fibrotic calcified plaques [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41092387\">",
"    <span class=\"h1\">",
"     HISTOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901080\">",
"    <span class=\"h2\">",
"     Fatty streaks",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first phase in atherosclerosis histologically presents as focal thickening of the intima with an increase in smooth muscle cells and extracellular matrix (",
"    <a class=\"graphic graphic_table graphicRef56922 \" href=\"UTD.htm?7/18/7468\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef76466 \" href=\"UTD.htm?9/16/9472\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/8\">",
"     8",
"    </a>",
"    ]. These smooth muscle cells, some of which may arise from hematopoietic stem cells [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/9\">",
"     9",
"    </a>",
"    ], migrate and proliferate within the intima. Lipids accumulate early in fatty streak formation yielding both intracellular lipid and extracellular deposits, which produce the fatty streak. Biglycan, a small dermatan sulfate proteoglycan, detected in the intima of atherosclerotic coronary artery segments can bind and trap lipoproteins, including apolipoprotein E, VLDL remnants, LDL, and HDL [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/10\">",
"     10",
"    </a>",
"    ]. The fatty streak also consists of macrophages with a variable number of T lymphocytes. (See",
"    <a class=\"local\" href=\"#H27901126\">",
"     'Inflammation'",
"    </a>",
"    below.) Macrophages engorged with lipids are called foam cells, the hallmark of the early atheroma.",
"   </p>",
"   <p>",
"    As these lesions expand, more smooth muscle cells migrate into the intima. The smooth muscle cells within the deep layer of the fatty streak are susceptible to apoptosis, which is associated with further macrophage accumulation and microvesicles that can calcify, perhaps contributing to the transition of fatty streaks into atherosclerotic plaques (",
"    <a class=\"graphic graphic_table graphicRef56922 \" href=\"UTD.htm?7/18/7468\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2525668183\">",
"    <span class=\"h2\">",
"     Fibrous cap",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fibrous cap atheromas are defined as plaques with a well-defined lipid core covered by a fibrous cap, which may be relatively acellular (made of dense collagen) or may be rich in smooth cells. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/15/20729?source=see_link\">",
"     \"Pathology and pathogenesis of the vulnerable plaque\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2525668191\">",
"    <span class=\"h2\">",
"     Vasa vasorum",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vasa vasorum form a network of micro-vasculature that originate primarily in the adventitial layer of large arteries. These vessels supply oxygen and nutrients to the outer layers of the arterial wall [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/12\">",
"     12",
"    </a>",
"    ]. As atherosclerotic plaques develop and expand, they acquire their own microvascular network (vasa vasorum) extending from the adventitia through the media and into the thickened intima [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/13\">",
"     13",
"    </a>",
"    ]. These thin-walled vessels are prone to disruption, leading to hemorrhage within the substance of the plaque and contributing to the progression of coronary atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901087\">",
"    <span class=\"h2\">",
"     Fibrous plaque",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fibrous plaque evolves from the fatty streak via accumulation of connective tissue with an increased number of smooth muscle cells filled with lipids and often a deeper extracellular lipid pool.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901094\">",
"    <span class=\"h2\">",
"     Advanced lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;More advanced lesions develop a microvasculature from both the luminal and medial aspects, and often contain a necrotic lipid rich core, which can eventually become calcified (",
"    <a class=\"graphic graphic_table graphicRef56922 \" href=\"UTD.htm?7/18/7468\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Advanced lesions are associated with coronary artery remodeling (",
"    <a class=\"graphic graphic_figure graphicRef68786 \" href=\"UTD.htm?34/58/35747\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/16\">",
"     16",
"    </a>",
"    ]. Positive remodeling is defined as a positive correlation between plaque and external elastic membrane area due to a compensatory increase in local vessel size in response to increasing plaque burden (dilated coronary atherosclerosis), while negative remodeling refers to a smaller external elastic membrane area at the lesion site due to the local shrinkage of vessel size (obstructive coronary atherosclerosis) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72935 graphicRef59588 \" href=\"UTD.htm?33/38/34409\">",
"     image 1A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Positive remodeling has been felt to be a compensatory mechanism in early coronary artery disease, preventing luminal loss despite plaque accumulation. However, arterial remodeling consequent to plaque formation and expansion is associated with abnormal arterial physiology as well as the development of clinical symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/16\">",
"     16",
"    </a>",
"    ]. Positive remodeling is seen with complex, unstable plaques in patients presenting with unstable angina; in contrast, negative remodeling is associated with smoother, stable plaques in patients with stable angina [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/7/25721?source=see_link\">",
"     \"The role of the vulnerable plaque in acute coronary syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901102\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple factors contribute to the pathogenesis of atherosclerosis, including endothelial dysfunction, dyslipidemia, inflammatory, and immunologic factors, plaque rupture, and smoking. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=see_link\">",
"     \"Overview of the risk equivalents and established risk factors for cardiovascular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1482?source=see_link\">",
"     \"Cardiovascular risk of smoking and benefits of smoking cessation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901110\">",
"    <span class=\"h2\">",
"     Endothelial dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The endothelium is an active biologic interface between the blood and all other tissues. The single layer of continuous endothelium lining arteries forms a unique thromboresistant layer between blood and potentially thrombogenic subendothelial tissues. The endothelium also modulates tone, growth, hemostasis, and inflammation throughout the circulatory system. Endothelial vasodilator dysfunction is an initial step in atherosclerosis and is felt to be caused principally by loss of endothelium-derived nitric oxide [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/18\">",
"     18",
"    </a>",
"    ]. This issue is discussed in detail separately and will only briefly be reviewed here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=see_link\">",
"     \"Endothelial dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endothelial dysfunction is associated with many of the traditional risk factors for atherosclerosis including hypercholesterolemia, diabetes, hypertension, cigarette smoking. In particular, endothelial dysfunction is induced by oxidized LDL and in some respects can be considered as a final common pathway (",
"    <a class=\"graphic graphic_table graphicRef56643 \" href=\"UTD.htm?0/50/812\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/19\">",
"     19",
"    </a>",
"    ]. It can be improved with correction of hyperlipidemia by diet or by therapy with a statin (HMG-coenzyme A reductase inhibitor), which increases the bioavailability of nitric oxide [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/20,21\">",
"     20,21",
"    </a>",
"    ], with ACE inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/22\">",
"     22",
"    </a>",
"    ], or with high doses of antioxidants such as vitamin C or flavonoids contained in red wine and purple grape juice [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. However, clinical benefits of these therapies have only been demonstrated convincingly for statins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=see_link\">",
"     \"Endothelial dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/2/32?source=see_link\">",
"     \"Mechanisms of benefit of lipid-lowering drugs in patients with coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26456?source=see_link\">",
"     \"Nutritional antioxidants in coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901126\">",
"    <span class=\"h2\">",
"     Inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence of inflammation in atherosclerotic lesions has been noted from the earliest histologic observations and inflammation is central to understanding the pathogenesis of atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]. Macrophages that have been modified by oxidized LDL release a variety of inflammatory substances, cytokines, and growth factors [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Among the many molecules that have been implicated are: monocyte chemotactic protein (MCP)-1 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]; intercellular adhesion molecule (ICAM)-1 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/31\">",
"     31",
"    </a>",
"    ]; macrophage and granulocyte-macrophage colony stimulating factors [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]; soluble CD40 ligand [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/35\">",
"     35",
"    </a>",
"    ]; interleukin (IL)-1, IL-3, IL-6, IL-8, and IL-18 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/35-38\">",
"     35-38",
"    </a>",
"    ]; and tumor necrosis factor alpha [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. The role of IL-6 is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=see_link&amp;anchor=H835935#H835935\">",
"     \"Overview of the risk equivalents and established risk factors for cardiovascular disease\", section on 'Interleukin-6'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Perhaps the best evidence supporting the importance of inflammation in the pathogenesis of atherosclerosis comes from the observation that markers of increased or decreased systemic inflammation associate with the risk of atherosclerosis. Some of these markers are discussed in the next sections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901134\">",
"    <span class=\"h3\">",
"     Serum CRP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best studied of these markers is the acute phase reactant C-reactive protein (CRP). Although CRP is consistently associated with atherosclerotic cardiovascular disease, its function as a causal risk factor has not been established. The role of CRP in cardiovascular disease is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27658?source=see_link\">",
"     \"C-reactive protein in cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41092680\">",
"    <span class=\"h3\">",
"     Lp-PLA2",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipoprotein-associated phospholipase A",
"    <sub>",
"     2",
"    </sub>",
"    (Lp-PLA",
"    <sub>",
"     2",
"    </sub>",
"    ) is an emerging inflammatory marker [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Lp-PLA",
"    <sub>",
"     2",
"    </sub>",
"    is a lipoprotein-associated, macrophage-secreted enzyme that perpetuates plaque inflammation and whose elevated levels predict a 40 to 400 percent (averaging about 100 percent) increased risk of myocardial infarction (MI) and stroke in population studies fully adjusted for other cardiovascular disease risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/44\">",
"     44",
"    </a>",
"    ]. Elevated Lp-PLA",
"    <sub>",
"     2",
"    </sub>",
"    and hsC reactive protein (CRP measured with a highly sensitive assay) in combination reproducibly identify low-, intermediate-, and high- (relative risk &gt;fourfold for coronary artery disease and &gt;10-fold for stroke) risk patients in moderate-risk populations [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/45\">",
"     45",
"    </a>",
"    ]. A consensus panel [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/46\">",
"     46",
"    </a>",
"    ] endorses the independent value of Lp-PLA",
"    <sub>",
"     2",
"    </sub>",
"    as well as its additive value to hs-CRP in assessing MI risk in moderate-risk populations [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/45,47,48\">",
"     45,47,48",
"    </a>",
"    ]. Lp-PLA",
"    <sub>",
"     2",
"    </sub>",
"    testing is not recommended for use in low-risk populations as a screening tool, but is recommended in persons assessed to be at moderate or high cardiovascular disease risk by traditional risk assessment. Based on the current state of knowledge, the consensus panel recommends that Lp-PLA",
"    <sub>",
"     2",
"    </sub>",
"    testing be used in conjunction with this simplified model of CVD risk assessment in non-low-risk individuals to identify persons who are at increased risk for heart attack",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901149\">",
"    <span class=\"h3\">",
"     Cytokines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cytokines play a pivotal role in the pathogenesis of atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/35,49\">",
"     35,49",
"    </a>",
"    ]. The release of proinflammatory cytokines is stimulated by LDL modification, free radical formation, hemodynamic stress, hypertension, and infection. These cytokines, especially interleukin-1 and tumor necrosis factor-alpha, have a multitude of atherogenic effects. They enhance the expression of cell surface molecules such as ICAM-1, VCAM-1, CD40, CD40L, and selectins on endothelial cells, smooth muscle cells, and macrophages. Pro-inflammatory cytokines can also induce cell proliferation, contribute to the production of reactive oxygen species, stimulate matrix metalloproteinases, and induce tissue factor expression. Other cytokines, such as interleukin-4 and interleukin-10, are antiatherogenic. Still others, such as interferon-gamma, have a variety of actions with both pro- and anti-atherogenic consequences. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/7/25721?source=see_link\">",
"     \"The role of the vulnerable plaque in acute coronary syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901163\">",
"    <span class=\"h3\">",
"     Leukocyte activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leukocyte (circulating monocytes, and to a lesser extent T lymphocytes) recruitment is seen early in the atherosclerotic lesion, providing some evidence of the role of systemic inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further evidence in support of systemic inflammation comes from a study in which the inflammatory mRNA profile of circulating leukocytes was tested in 524 men with a prior myocardial infarction and 628 controls [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/51\">",
"     51",
"    </a>",
"    ]. The patients, compared to controls, had mRNA profiles showing increased levels of most inflammatory mRNAs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901170\">",
"    <span class=\"h3\">",
"     Toll-like receptor 4",
"    </span>",
"    &nbsp;&mdash;&nbsp;Further evidence for the role of inflammation comes from study of polymorphisms in the toll-like receptor 4 gene that confer differences in the inflammatory response to Gram negative pathogens and perhaps other ligands [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/52\">",
"     52",
"    </a>",
"    ]. A particular polymorphism of this gene, Asp299Gly, presents in 7 percent of an Italian population, diminishes receptor cycling, and is associated with diminished inflammatory response to gram-negative pathogens.",
"   </p>",
"   <p>",
"    Carriers of the Asp299Gly polymorphism, compared to patients with only wild-type alleles, have reduced circulating levels of a variety of inflammatory markers, including CRP, adhesion molecules, and IL-6, and a reduced incidence of carotid atherosclerosis (odds ratio 0.54) as detected by ultrasonography. They have an increased rate of serious bacterial infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41093640\">",
"    <span class=\"h2\">",
"     Dyslipidemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipid abnormalities play a critical role in the development of atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/30,53-59\">",
"     30,53-59",
"    </a>",
"    ]. Early experiments in animals demonstrated accelerated atherosclerosis with a high cholesterol diet. This was followed by epidemiologic studies conducted in countries around the world that showed an increasing incidence of atherosclerosis when serum cholesterol concentrations were above 150",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (3.9",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef60146 \" href=\"UTD.htm?0/19/317\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The role of the different lipid particles in the development of atherosclerosis is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18138?source=see_link\">",
"     \"Lipoprotein classification; metabolism; and role in atherosclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is useful, however, to summarize the major observations.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      High levels of low density lipoprotein (LDL) cholesterol [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/53,59\">",
"       53,59",
"      </a>",
"      ] and low levels of high density lipoprotein (HDL) cholesterol are particularly important risk factors for atherosclerosis (",
"      <a class=\"graphic graphic_algorithm graphicRef70984 \" href=\"UTD.htm?15/49/16157\">",
"       algorithm 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      LDL accumulates in the cholesterol ester-enriched macrophages (foam cells), but not the lipid core, of atherosclerotic plaque [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/60\">",
"       60",
"      </a>",
"      ]. Oxidative modification of LDL is a prerequisite for macrophage uptake via unregulated macrophage scavenger receptors (among them CD36, also called scavenger receptor B) and for accelerated accumulation of cholesterol [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/61,62\">",
"       61,62",
"      </a>",
"      ]. Macrophage uptake of LDL cholesterol may initially be an adaptive response, which prevents LDL-induced endothelial injury [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/63\">",
"       63",
"      </a>",
"      ]. However, cholesterol accumulation in foam cells leads to mitochondrial dysfunction, apoptosis, and necrosis, with resultant release of cellular proteases, inflammatory cytokines, and prothrombotic molecules [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Oxidized LDL can cause disruption of the endothelial cell surface [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/64\">",
"       64",
"      </a>",
"      ], promote inflammatory and immune changes via cytokine release from macrophages and antibody production (see",
"      <a class=\"local\" href=\"#H27901229\">",
"       'Anti-oxidized LDL antibodies'",
"      </a>",
"      below), and increase platelet aggregation. It may also play a role in plaque instability. Levels of oxidized LDL are increased in patients with an acute coronary syndrome and are positively correlated with the severity of the syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/65,66\">",
"       65,66",
"      </a>",
"      ]. Measurement of oxidized LDL has not been standardized or validated as a clinically useful biomarker, however.",
"     </li>",
"     <li>",
"      HDL, in contrast to LDL, has antiatherogenic properties that include reverse cholesterol transport, maintenance of endothelial function, and protection against thrombosis. The net effect is that there is an inverse relationship between plasma HDL-cholesterol levels and cardiovascular risk (",
"      <a class=\"graphic graphic_table graphicRef57480 \" href=\"UTD.htm?0/2/35\">",
"       table 3",
"      </a>",
"      ). Values above 75",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.9",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      are associated with a longevity syndrome. Values above 60",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.5",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      count as a negative risk factor in the Framingham Risk Assessment [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/67\">",
"       67",
"      </a>",
"      ]. However, cardiovascular disease event reduction from increasing HDL is under investigations and has not been established. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/2/39978?source=see_link\">",
"       \"HDL metabolism and approach to the patient with abnormal HDL-cholesterol levels\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The role of hypertriglyceridemia is less clear because confirmation of its specific role is made difficult by its association with low serum HDL. Coronary risk appears to increase at serum triglyceride values above 200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (2.3",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      or perhaps lower [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/68,69\">",
"       68,69",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35578?source=see_link\">",
"       \"Approach to the patient with hypertriglyceridemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The role of lipoprotein(a), which is a combination of the LDL lipoprotein molecule and apolipoprotein a, remains controversial. Lp(a) binding to macrophages could lead to foam cell formation and localization of Lp(a) at atherosclerotic plaques [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/70\">",
"       70",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40248?source=see_link\">",
"       \"Lipoprotein(a) and cardiovascular disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41094192\">",
"    <span class=\"h2\">",
"     Hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertension is a major risk factor for the development of atherosclerosis, particularly in the coronary and cerebral circulations [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/71-74\">",
"     71-74",
"    </a>",
"    ]. It can increase arterial wall tension, potentially leading to disturbed repair processes and aneurysm formation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41094212\">",
"    <span class=\"h2\">",
"     Smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cigarette smoking is another major risk factor [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/71-74\">",
"     71-74",
"    </a>",
"    ] and it impacts all phases of atherosclerosis from endothelial dysfunction to acute clinical events, the latter being largely thrombotic [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/75\">",
"     75",
"    </a>",
"    ].The following observations have been made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In humans, cigarette smoke exposure impairs endothelium-dependent vasodilation (EDV) perhaps through decreased nitric oxide (NO) availability [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/76-78\">",
"       76-78",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cigarette smoking is associated with an increased level of multiple inflammatory markers, including C-reactive protein, interleukin-6, and tumor necrosis factor alpha in both male and female smokers [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/79-82\">",
"       79-82",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cigarette smoking may decrease availability of platelet-derived NO, decrease platelet sensitivity to exogenous NO (both of which may lead to increased activation and adhesion) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/83,84\">",
"       83,84",
"      </a>",
"      ], increase fibrinogen levels [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/85,86\">",
"       85,86",
"      </a>",
"      ], and decrease fibrinolysis [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/87\">",
"       87",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cigarette smoking increases oxidative modification of LDL [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/88\">",
"       88",
"      </a>",
"      ] and decreases the plasma activity of paraoxonase, an enzyme that protects against LDL oxidation [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/89\">",
"       89",
"      </a>",
"      ]. The",
"      <span class=\"nowrap\">",
"       triglyceride/high-density",
"      </span>",
"      lipoprotein abnormalities seen among smokers have recently been suggested to be related to insulin resistance [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/90\">",
"       90",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41094220\">",
"    <span class=\"h2\">",
"     Diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to atherogenic effects from the diabetes-related dyslipidemia (elevated triglycerides, low level of HDL-C, and",
"    <span class=\"nowrap\">",
"     small/dense",
"    </span>",
"    LDL particles), as mentioned above, there have been many clinical and experimental studies revealing that high levels of insulin precede development of arterial diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/91-97\">",
"     91-97",
"    </a>",
"    ]. Macrophages are known to express most insulin signaling molecules except IR substrate 1 (IRS1) and glucose transporter type 4 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/98,99\">",
"     98,99",
"    </a>",
"    ]. Even though insulin activates the",
"    <span class=\"nowrap\">",
"     IR/IRS2/PI3K/Akt",
"    </span>",
"    pathway in macrophages as in other types of insulin-responsive cells, there have been few studies investigating the biological functions of insulin signaling in macrophages. A recently published study [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/100\">",
"     100",
"    </a>",
"    ] evaluated if insulin affects macrophage foam cell formation and found that insulin increased the expression of CD36 and decreased ABCA-1 expression, which may promote cholesterol accumulation in human monocyte-derived macrophages. The study also showed that low concentration of adiponectin increased the phosphorylation of Akt (Ser436) by the same degree as insulin and had the same modulating effect on CD36 and ABCA-1 as insulin. Atherosclerosis and type 2 diabetes share similar pathological mechanisms, including elevation in cytokines like MCP-1 and interleukin-6 (IL-6), which contribute to underlying inflammation of both [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/101\">",
"     101",
"    </a>",
"    ]. Oxidized LDL is abundant in both of these conditions and is known to induce secretion of these proinflammatory cytokines in macrophages [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/102\">",
"     102",
"    </a>",
"    ]. Clinically, the overall risk increase conferred by type 2 diabetes is driven by accelerated progression of pre-existing atherosclerosis to clinical cardiovascular events; vascular risk is much lower in diabetic patients without pre-existing significant coronary artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901191\">",
"    <span class=\"h2\">",
"     Tissue factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue factor is the primary initiator of coagulation and, in advanced atherosclerosis, is found in the plaque. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/35/27194?source=see_link\">",
"     \"Overview of hemostasis\"",
"    </a>",
"    .) Tissue factor, as well as other factors such as enhanced platelet activity, may contribute to the development of thrombosis following plaque rupture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/7/25721?source=see_link\">",
"     \"The role of the vulnerable plaque in acute coronary syndromes\"",
"    </a>",
"    .) Tissue factor also plays a role in the progression of atherosclerosis via coagulation-dependent and coagulation-independent mechanisms. In one study, tissue factor overexpression increased neointimal area and plaque size by increasing mural thrombus and smooth muscle cell migration and accelerating endothelial regrowth over the plaque after rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901199\">",
"    <span class=\"h2\">",
"     Angiotensin II",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased plasma concentrations of angiotensin II promote the development and severity of atherosclerosis, particularly when combined with hyperlipidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/105\">",
"     105",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"    Angiotensin II may play a role in the modulation of vascular smooth muscle cell proliferation and the production of extracellular matrix [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/106,107\">",
"     106,107",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36825?source=see_link\">",
"     \"Actions of angiotensin II on the heart\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901207\">",
"    <span class=\"h2\">",
"     Endothelin-1",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endothelin-1 may contribute to the pathogenesis of atherosclerosis at all stages, even when the plaque is clinically imperceptible [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/108,109\">",
"     108,109",
"    </a>",
"    ]. Endothelin-1 is a potent vasoconstrictor as well as a mitogen for vascular smooth muscle cells, stimulating their migration and growth. Oxidized LDL can stimulate its production and enhance its vasoconstrictor effects [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/110\">",
"     110",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11592?source=see_link\">",
"     \"Role of endothelin in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endothelin-1 immunoreactivity is ubiquitous within the intracellular and extracellular compartments of human coronary atherosclerotic tissue and is released from these sites in response to mechanical stress [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/111\">",
"     111",
"    </a>",
"    ]. In addition, endothelin-converting enzyme-1, the final enzyme for endothelin-1 production, is expressed in smooth muscle cells and macrophages of human coronary atherosclerotic lesions at all stages of development [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/109,112\">",
"     109,112",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901215\">",
"    <span class=\"h2\">",
"     Adhesion molecules",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) are cell surface glycoproteins induced at endothelial sites of inflammation that are responsible in part for the adherence of leukocytes to endothelium. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/54/36711?source=see_link\">",
"     \"Leukocyte-endothelial adhesion in the pathogenesis of inflammation\"",
"    </a>",
"    .) A low level of ICAM-1 is expressed on normal endothelial cells and is seen in normal arterial segments, while VCAM-1 expression occurs only with inflammation and is present in the microvessels of human atherosclerotic lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/113\">",
"     113",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The expression of both ICAM-1 and VCAM-1 are upregulated in atherosclerotic lesions, but VCAM-1 appears to be more important in the initiation of atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/114\">",
"     114",
"    </a>",
"    ]. P-selectin, a platelet and endothelial cell receptor that mediates adhesion between vascular cells, also may promote migration of inflammatory cells into early and advanced atherosclerotic lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/115,116\">",
"     115,116",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Monocyte adhesion to endothelial cells is reduced by L-arginine, the precursor of nitric oxide [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/117\">",
"     117",
"    </a>",
"    ] and alpha tocopherol (vitamin E) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/118\">",
"     118",
"    </a>",
"    ], and increased by androgens due in part to enhanced endothelial cell-surface expression of VCAM-1 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/119\">",
"     119",
"    </a>",
"    ]. Antibodies that block adhesion molecules may ameliorate elements of the inflammatory response in atherosclerotic plaques [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/120\">",
"     120",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901222\">",
"    <span class=\"h2\">",
"     Flow characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequent occurrence of atheroma at sites of bends, branches, and bifurcations of coronary arteries suggests that",
"    <strong>",
"    </strong>",
"    altered blood flow and low shear stress can play a role in the development of atherosclerosis. Low shear stress, which is a result of disrupted laminar blood flow, can alter endothelial cell function [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/121\">",
"     121",
"    </a>",
"    ], and is less likely to impair adhesive interactions between leukocytes and the vessel wall, possibly leading to enhanced monocyte binding and an increase in LDL accumulation and modification [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/29\">",
"     29",
"    </a>",
"    ]. These changes may be mediated by stimulation of the release of nitric oxide from the endothelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/122\">",
"     122",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Atherosclerosis preferentially affects regions of coronary arteries which experience low shear stress or disturbed flow [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/123\">",
"     123",
"    </a>",
"    ]. In addition, low shear stress is associated with an increase in intima medial thickness of the common carotid artery in healthy men [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/124\">",
"     124",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901229\">",
"    <span class=\"h2\">",
"     Anti-oxidized LDL antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oxidation of LDL involves the oxidation of fatty acids that produce hydroperoxides and generate active aldehydes such as malondialdehyde [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/125\">",
"     125",
"    </a>",
"    ]. Malondialdehyde can modify the lysine residues on apolipoprotein B, which renders the molecule more attractive to the scavenger receptor on the macrophage.",
"    <strong>",
"    </strong>",
"    The oxidized LDL, modified by oxidation or by derivatization of the lysyl residues, can become antigenic.",
"   </p>",
"   <p>",
"    Antibodies to oxidized LDL localize in human atherosclerotic plaques and in the plasma of patients with atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/126,127\">",
"     126,127",
"    </a>",
"    ]. The titer of antibodies to oxidized LDL rise during the month after presentation with an acute coronary syndrome and are higher than in patients with chronic coronary disease or normal coronary arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/66\">",
"     66",
"    </a>",
"    ]. This issue is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/53/40792?source=see_link&amp;anchor=H4#H4\">",
"     \"Function and clinical applications of immunoglobulins\", section on 'Antibody specificity and cross-reactivity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901244\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic infection may contribute to the pathogenesis of atherosclerosis. The major organisms that have been studied are Chlamydophila (formerly Chlamydia) pneumoniae, cytomegalovirus (CMV), and Helicobacter pylori; however, enterovirus (primarily coxsackie B virus), hepatitis A virus (HAV), and herpes simplex virus (HSV) type 1 and type 2 have also been implicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34394?source=see_link&amp;anchor=H10122216#H10122216\">",
"     \"Overview of the possible risk factors for cardiovascular disease\", section on 'Infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chronic infection could act by a number of mechanisms, including direct vascular injury and induction of a systemic inflammatory state (See",
"    <a class=\"local\" href=\"#H27901126\">",
"     'Inflammation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Despite the attractiveness of infection as a potential important contributing factor, clinical evidence to support its role is lacking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901252\">",
"    <span class=\"h3\">",
"     C. pneumoniae infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. pneumoniae has been the focus of much attention as a possible contributor to coronary atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/128,129\">",
"     128,129",
"    </a>",
"    ]. However, large randomized trials do",
"    <strong>",
"     not",
"    </strong>",
"    support benefit from antibiotic therapy against C. pneumoniae to reduce coronary events. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25160?source=see_link\">",
"     \"Chlamydophila (Chlamydia) pneumoniae infection as a potential etiologic factor in atherosclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901259\">",
"    <span class=\"h3\">",
"     Cytomegalovirus infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection with CMV and other herpesviruses, such as HSV, has been implicated in some but not all studies in the development of atherosclerosis, restenosis, and transplant vasculopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/130-135\">",
"     130-135",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum anti-CMV antibody levels are significantly elevated in patients with coronary disease when compared to control subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/131,136\">",
"     131,136",
"    </a>",
"    ] and in those with carotid intimal thickening (a measure of subclinical atherosclerosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/137\">",
"     137",
"    </a>",
"    ]. In addition, CMV antigens, nucleic acid sequences, and DNA have been detected in smooth muscle cells of carotid artery plaques obtained from patients undergoing endarterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/138\">",
"     138",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CMV infection might promote the development of atherosclerosis by increasing the uptake of oxidized LDL in vascular smooth muscle cells [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/139\">",
"     139",
"    </a>",
"    ] and by increasing the neointimal response to vascular injury [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/140\">",
"     140",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901267\">",
"    <span class=\"h3\">",
"     Coxsackie B virus infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;A role has been postulated for the enterovirus coxsackie B virus in the pathogenesis of coronary heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/141\">",
"     141",
"    </a>",
"    ]. However, no rigorous evidence exists to support its role in atherosclerosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901274\">",
"    <span class=\"h3\">",
"     H. pylori",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is also some evidence linking H. pylori infection with atherosclerosis and premature myocardial infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/142,143\">",
"     142,143",
"    </a>",
"    ]. However, it is uncertain if this relationship is based upon the bacterium itself or its association with other confounding factors related to atherosclerosis, primarily lower socioeconomic class, older age, and smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/144\">",
"     144",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901282\">",
"    <span class=\"h3\">",
"     Pathogen burden",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to individual infections, the total pathogen burden, ie, the number of pathogens to which an individual has been exposed, may be an important risk factor for atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/145-148\">",
"     145-148",
"    </a>",
"    ]. This was illustrated in a report of 375 patients undergoing coronary angiography; antibody titers to a number of pathogens were measured and assessment of coronary endothelial function was performed in 218 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/146\">",
"     146",
"    </a>",
"    ]. The pathogen burden, more than any single pathogen, correlated with the presence and severity of coronary disease and was an independent predictor of endothelial dysfunction. The likelihood of atherosclerosis was markedly increased in patients with four or five positive titers and elevated serum CRP.",
"   </p>",
"   <p>",
"    Pathogen burden with atherosclerotic lesions has been directly assessed by testing for bacterial rDNA signatures by polymerase chain reaction in specimens obtained during catheter-based atherectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/149\">",
"     149",
"    </a>",
"    ]. Bacterial DNA was found in all patients with a mean of 12 species per lesion; bacterial DNA was not seen in control material or any unaffected coronary arteries. It is possible that secondary colonization may accelerate disease progression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901289\">",
"    <span class=\"h3\">",
"     Effect of antimicrobial therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the above data regarding the possible role of infectious pathogens in atherosclerosis, it has been suggested that antimicrobial therapy might reduce coronary risk. A small trial assessed the efficacy of two antibiotic regimens directed against C. pneumoniae and H. pylori in 325 patients with an acute coronary syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/150\">",
"     150",
"    </a>",
"    ]. Patients treated with antibiotics for one week, when compared to placebo, had a significant reduction in cardiac events (primarily admission for unstable angina) at 12 weeks and one year. However, the benefit was unrelated to the antibody status against either organism. How this effect might occur is not clear. One possibility is activity against other infectious organisms, reducing the total infectious burden.",
"   </p>",
"   <p>",
"    Two other studies have suggested a protective effect of prior exposure to antibiotics:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a population-based, case-control study (3315 cases and over 13,000 controls), the use of antibiotics was evaluated in subjects who did or did not have a first acute MI [",
"      <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/151\">",
"       151",
"      </a>",
"      ]. The cases with a first infarction were significantly less likely to have used a quinolone (adjusted odds ratio 0.45) or a",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"       tetracycline",
"      </a>",
"      (adjusted odds ratio 0.70); there was no association with previous use of macrolides, sulfonamides, penicillins, or cephalosporins.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another case-control compared antibiotic use among 244 type 2 diabetics with a first hospitalization for coronary heart disease and 686 matched diabetic controls without coronary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/152\">",
"     152",
"    </a>",
"    ]. The use of quinolones for more than 14 days in the three years prior to the event was associated with a significantly lower risk of coronary disease (adjusted odds ratio 0.30 compared to no quinolone use). There was no such association with other classes of antibiotics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27901297\">",
"    <span class=\"h3\">",
"     Effect of vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaccination against influenza has been evaluated for a potential benefit in preventing cardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/153-155\">",
"     153-155",
"    </a>",
"    ]. Several studies have found a beneficial effect of influenza vaccination on cardiovascular events [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/153,154\">",
"     153,154",
"    </a>",
"    ]. While these studies are of interest and do document a beneficial effect of influenza vaccination in older adults, they do not establish a causative relationship between influenza infection and the pathogenesis of atherosclerosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=see_link&amp;anchor=H14#H14\">",
"     \"Seasonal influenza vaccination in adults\", section on 'Elderly patients'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/18/38186?source=see_link&amp;anchor=H11#H11\">",
"     \"Geriatric health maintenance\", section on 'Influenza vaccine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41093121\">",
"    <span class=\"h1\">",
"     ROLE OF PLAQUE RUPTURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atherosclerosis is generally asymptomatic until the plaque stenosis exceeds 70 or 80 percent of the luminal diameter, which can produce a reduction in flow, as with coronary blood flow to myocardium. These stenotic lesions can produce typical symptoms of angina pectoris.",
"   </p>",
"   <p>",
"    Acute coronary and cerebrovascular syndromes (unstable angina, myocardial infarction, sudden death, and stroke) are typically due to rupture of plaques with less than 50 percent stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/156-158\">",
"     156-158",
"    </a>",
"    ]. Plaque rupture may also be silent; repeated silent ruptures and thrombosis, followed by wound healing, may cause progression of atherosclerosis, with an increase in plaque burden and percent stenosis and negative arterial remodeling [",
"    <a class=\"abstract\" href=\"UTD.htm?27/17/27930/abstract/159\">",
"     159",
"    </a>",
"    ]. The pathology and pathogenesis of the vulnerable plaque and its role in acute coronary syndromes are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/15/20729?source=see_link\">",
"     \"Pathology and pathogenesis of the vulnerable plaque\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/7/25721?source=see_link\">",
"     \"The role of the vulnerable plaque in acute coronary syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (See",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/5/23635?source=see_link\">",
"       \"Patient information: Atherosclerosis (The Basics)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11408436\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although atherosclerosis is one of the most studied human diseases, an agreed upon unifying hypothesis that fully explains its pathogenesis remains elusive.",
"     </li>",
"     <li>",
"      Multiple factors contribute to the pathogenesis of atherosclerosis including endothelial dysfunction, inflammatory and immunologic factors, plaque rupture, and the traditional risk factors of hypertension, diabetes, dyslipidemia, and smoking. Despite the attractiveness of infection as a potential contributing factor, clinical evidence to support its role is lacking. (See",
"      <a class=\"local\" href=\"#H27901102\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Atherosclerosis begins in childhood with the development of fatty streaks. The advanced lesions of atherosclerosis occur with increasing frequency with aging. (See",
"      <a class=\"local\" href=\"#H27901064\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The histologic stages of atherosclerosis include fatty streak, fibrous cap, fibrous plaques, and advances lesions. (See",
"      <a class=\"local\" href=\"#H41092387\">",
"       'Histology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/1\">",
"      Faxon DP, Fuster V, Libby P, et al. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation 2004; 109:2617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/2\">",
"      Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/3\">",
"      Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995; 92:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/4\">",
"      Tuzcu EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001; 103:2705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/5\">",
"      McGill HC Jr, McMahan CA, Zieske AW, et al. Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth. Circulation 2000; 102:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/6\">",
"      Strong JP, Malcom GT, McMahan CA, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999; 281:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/7\">",
"      van Dijk RA, Virmani R, von der Th&uuml;sen JH, et al. The natural history of aortic atherosclerosis: a systematic histopathological evaluation of the peri-renal region. Atherosclerosis 2010; 210:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/8\">",
"      Davies MJ, Woolf N, Rowles PM, Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J 1988; 60:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/9\">",
"      Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/10\">",
"      O'Brien KD, Olin KL, Alpers CE, et al. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation 1998; 98:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/11\">",
"      Kockx MM, De Meyer GR, Muhring J, et al. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 1998; 97:2307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/12\">",
"      Heistad DD, Marcus ML, Larsen GE, Armstrong ML. Role of vasa vasorum in nourishment of the aortic wall. Am J Physiol 1981; 240:H781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/13\">",
"      Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984; 310:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/14\">",
"      Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349:2316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/15\">",
"      Virmani R, Narula J, Farb A. When neoangiogenesis ricochets. Am Heart J 1998; 136:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/16\">",
"      Schoenhagen P, Ziada KM, Vince DG, et al. Arterial remodeling and coronary artery disease: the concept of \"dilated\" versus \"obstructive\" coronary atherosclerosis. J Am Coll Cardiol 2001; 38:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/17\">",
"      Schoenhagen P, Ziada KM, Kapadia SR, et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes : an intravascular ultrasound study. Circulation 2000; 101:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/18\">",
"      Kitta Y, Obata JE, Nakamura T, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 2009; 53:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/19\">",
"      Anderson TJ, Meredith IT, Charbonneau F, et al. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation 1996; 93:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/20\">",
"      Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987; 80:1808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/21\">",
"      John S, Schlaich M, Langenfeld M, et al. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation 1998; 98:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/22\">",
"      Mancini GB, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996; 94:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/23\">",
"      Levine GN, Frei B, Koulouris SN, et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/24\">",
"      Stein JH, Keevil JG, Wiebe DA, et al. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 1999; 100:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/25\">",
"      Paoletti R, Gotto AM Jr, Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation 2004; 109:III20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/26\">",
"      Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/27\">",
"      Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54:2129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/28\">",
"      Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011; 17:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/29\">",
"      Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91:2488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/30\">",
"      Steinberg D, Witztum JL. Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30:2311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/31\">",
"      Gawaz M, Neumann FJ, Dickfeld T, et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 1998; 98:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/32\">",
"      Tsao PS, Wang B, Buitrago R, et al. Nitric oxide regulates monocyte chemotactic protein-1. Circulation 1997; 96:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/33\">",
"      Takahashi M, Kitagawa S, Masuyama JI, et al. Human monocyte-endothelial cell interaction induces synthesis of granulocyte-macrophage colony-stimulating factor. Circulation 1996; 93:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/34\">",
"      Rajavashisth T, Qiao JH, Tripathi S, et al. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. J Clin Invest 1998; 101:2702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/35\">",
"      Szmitko PE, Wang CH, Weisel RD, et al. New markers of inflammation and endothelial cell activation: Part I. Circulation 2003; 108:1917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/36\">",
"      Rectenwald JE, Moldawer LL, Huber TS, et al. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 2000; 102:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/37\">",
"      Brizzi MF, Formato L, Dentelli P, et al. Interleukin-3 stimulates migration and proliferation of vascular smooth muscle cells: a potential role in atherogenesis. Circulation 2001; 103:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/38\">",
"      Simonini A, Moscucci M, Muller DW, et al. IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation 2000; 101:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/39\">",
"      Li H, Freeman MW, Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 1995; 95:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/40\">",
"      Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000; 102:2636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/41\">",
"      Kaartinen M, Penttil&auml; A, Kovanen PT. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation 1996; 94:2787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/42\">",
"      Alderliesten T, de Vries LS, Benders MJ, et al. MR Imaging and Outcome of Term Neonates with Perinatal Asphyxia: Value of Diffusion-weighted MR Imaging and H MR Spectroscopy. Radiology 2011; 261:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/43\">",
"      Rosenson RS, Hurt-Camejo E. Phospholipase A2 enzymes and the risk of atherosclerosis. Eur Heart J 2012; 33:2899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/44\">",
"      Garza CA, Montori VM, McConnell JP, et al. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc 2007; 82:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/45\">",
"      Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004; 109:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/46\">",
"      Davidson MH, Corson MA, Alberts MJ, et al. Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines. Am J Cardiol 2008; 101:51F.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/47\">",
"      Koenig W, Khuseyinova N, L&ouml;wel H, et al. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany. Circulation 2004; 110:1903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/48\">",
"      May HT, Horne BD, Anderson JL, et al. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death. Am Heart J 2006; 152:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/49\">",
"      Young JL, Libby P, Sch&ouml;nbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 2002; 88:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/50\">",
"      Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006; 47:C7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/51\">",
"      Wettinger SB, Doggen CJ, Spek CA, et al. High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells. Blood 2005; 105:2000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/52\">",
"      Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/53\">",
"      Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med 1988; 148:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/54\">",
"      Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/55\">",
"      Romm PA, Green CE, Reagan K, Rackley CE. Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. Am J Cardiol 1991; 67:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/56\">",
"      Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992; 85:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/57\">",
"      Criqui MH, Heiss G, Cohn R, et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993; 328:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/58\">",
"      Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular M&uuml;nster study. Am J Cardiol 1992; 70:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/59\">",
"      Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269:3015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/60\">",
"      Iuliano L, Mauriello A, Sbarigia E, et al. Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque : effect of vitamin E supplementation. Circulation 2000; 101:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/61\">",
"      Podrez EA, Febbraio M, Sheibani N, et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest 2000; 105:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/62\">",
"      Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001; 108:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/63\">",
"      Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 2002; 110:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/64\">",
"      Vink H, Constantinescu AA, Spaan JA. Oxidized lipoproteins degrade the endothelial surface layer : implications for platelet-endothelial cell adhesion. Circulation 2000; 101:1500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/65\">",
"      Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001; 103:1955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/66\">",
"      Tsimikas S, Bergmark C, Beyer RW, et al. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 2003; 41:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/67\">",
"      National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/68\">",
"      Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007; 115:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/69\">",
"      Sarwar N, Sattar N. Triglycerides and coronary heart disease: have recent insights yielded conclusive answers? Curr Opin Lipidol 2009; 20:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/70\">",
"      Zioncheck TF, Powell LM, Rice GC, et al. Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. J Clin Invest 1991; 87:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/71\">",
"      DAWBER TR, MEADORS GF, MOORE FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 1951; 41:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/72\">",
"      Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular M&uuml;nster (PROCAM) study. Circulation 2002; 105:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/73\">",
"      Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/74\">",
"      Frohlich J, Al-Sarraf A. Cardiovascular risk and atherosclerosis prevention. Cardiovasc Pathol 2013; 22:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/75\">",
"      Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004; 43:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/76\">",
"      Mayhan WG, Sharpe GM. Effect of cigarette smoke extract on arteriolar dilatation in vivo. J Appl Physiol 1996; 81:1996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/77\">",
"      Mayhan WG, Patel KP. Effect of nicotine on endothelium-dependent arteriolar dilatation in vivo. Am J Physiol 1997; 272:H2337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/78\">",
"      Ota Y, Kugiyama K, Sugiyama S, et al. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract--role of free radicals and attenuation by captopril. Atherosclerosis 1997; 131:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/79\">",
"      Tracy RP, Psaty BM, Macy E, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 1997; 17:2167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/80\">",
"      Bermudez EA, Rifai N, Buring JE, et al. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002; 89:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/81\">",
"      Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997; 78:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/82\">",
"      Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF. Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci (Lond) 1995; 88:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/83\">",
"      Ichiki K, Ikeda H, Haramaki N, et al. Long-term smoking impairs platelet-derived nitric oxide release. Circulation 1996; 94:3109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/84\">",
"      Sawada M, Kishi Y, Numano F, Isobe M. Smokers lack morning increase in platelet sensitivity to nitric oxide. J Cardiovasc Pharmacol 2002; 40:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/85\">",
"      Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987; 113:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/86\">",
"      Smith FB, Lee AJ, Fowkes FG, et al. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997; 17:3321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/87\">",
"      Barua RS, Ambrose JA, Saha DC, Eales-Reynolds LJ. Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstration. Circulation 2002; 106:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/88\">",
"      Heitzer T, Yl&auml;-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996; 93:1346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/89\">",
"      Nishio E, Watanabe Y. Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols. Biochem Biophys Res Commun 1997; 236:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/90\">",
"      Reaven G, Tsao PS. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol 2003; 41:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/91\">",
"      Py&ouml;r&auml;la K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/92\">",
"      Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/93\">",
"      Ducimetiere P, Eschwege E, Papoz L, et al. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980; 19:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/94\">",
"      Py&ouml;r&auml;l&auml; K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl 1985; 701:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/95\">",
"      Eschwege E, Richard JL, Thibult N, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res Suppl 1985; 15:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/96\">",
"      Haffner SM, Stern MP, Hazuda HP, et al. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1986; 315:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/97\">",
"      R&ouml;nnemaa T, Laakso M, Py&ouml;r&auml;l&auml; K, et al. High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb 1991; 11:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/98\">",
"      Welham MJ, Bone H, Levings M, et al. Insulin receptor substrate-2 is the major 170-kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells. J Biol Chem 1997; 272:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/99\">",
"      Malide D, Davies-Hill TM, Levine M, Simpson IA. Distinct localization of GLUT-1, -3, and -5 in human monocyte-derived macrophages: effects of cell activation. Am J Physiol 1998; 274:E516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/100\">",
"      Park YM, R Kashyap S, A Major J, Silverstein RL. Insulin promotes macrophage foam cell formation: potential implications in diabetes-related atherosclerosis. Lab Invest 2012; 92:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/101\">",
"      Fern&aacute;ndez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/102\">",
"      Miller YI, Viriyakosol S, Worrall DS, et al. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005; 25:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/103\">",
"      Saely CH, Rein P, Vonbank A, et al. Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular events. Int J Cardiol 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/104\">",
"      Hasenstab D, Lea H, Hart CE, et al. Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis. Circulation 2000; 101:2651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/105\">",
"      Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000; 105:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/106\">",
"      Potter DD, Sobey CG, Tompkins PK, et al. Evidence that macrophages in atherosclerotic lesions contain angiotensin II. Circulation 1998; 98:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/107\">",
"      Strawn WB, Chappell MC, Dean RH, et al. Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 2000; 101:1586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/108\">",
"      Lerman A, Edwards BS, Hallett JW, et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/109\">",
"      Ihling C, Szombathy T, Bohrmann B, et al. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 2001; 104:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/110\">",
"      Mathew V, Cannan CR, Miller VM, et al. Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia. Circulation 1997; 96:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/111\">",
"      Hasdai D, Holmes DR Jr, Garratt KN, et al. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation 1997; 95:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/112\">",
"      Minamino T, Kurihara H, Takahashi M, et al. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation 1997; 95:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/113\">",
"      Iiyama K, Hajra L, Iiyama M, et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999; 85:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/114\">",
"      Cybulsky MI, Iiyama K, Li H, et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001; 107:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/115\">",
"      Johnson RC, Chapman SM, Dong ZM, et al. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest 1997; 99:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/116\">",
"      Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 2000; 101:2290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/117\">",
"      Adams MR, Jessup W, Hailstones D, Celermajer DS. L-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules. Circulation 1997; 95:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/118\">",
"      Islam KN, Devaraj S, Jialal I. alpha-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation 1998; 98:2255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/119\">",
"      McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 1999; 99:2317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/120\">",
"      Patel SS, Thiagarajan R, Willerson JT, Yeh ET. Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation 1998; 97:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/121\">",
"      Hagiwara H, Mitsumata M, Yamane T, et al. Laminar shear stress-induced GRO mRNA and protein expression in endothelial cells. Circulation 1998; 98:2584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/122\">",
"      Tsao PS, Buitrago R, Chan JR, Cooke JP. Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1. Circulation 1996; 94:1682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/123\">",
"      Nwasokwa ON, Weiss M, Gladstone C, Bodenheimer MM. Effect of coronary artery size on the prevalence of atherosclerosis. Am J Cardiol 1996; 78:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/124\">",
"      Gnasso A, Carallo C, Irace C, et al. Association between intima-media thickness and wall shear stress in common carotid arteries in healthy male subjects. Circulation 1996; 94:3257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/125\">",
"      Holvoet P, Perez G, Zhao Z, et al. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest 1995; 95:2611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/126\">",
"      Inoue T, Uchida T, Kamishirado H, et al. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 2001; 37:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/127\">",
"      Bui MN, Sack MN, Moutsatsos G, et al. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Am Heart J 1996; 131:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/128\">",
"      Capron L. Chlamydia in coronary plaques--hidden culprit or harmless hobo? Nat Med 1996; 2:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/129\">",
"      Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996; 27:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/130\">",
"      Adler SP, Hur JK, Wang JB, Vetrovec GW. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis 1998; 177:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/131\">",
"      Blum A, Giladi M, Weinberg M, et al. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 1998; 81:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/132\">",
"      Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 1998; 98:2796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/133\">",
"      Sorlie PD, Nieto FJ, Adam E, et al. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med 2000; 160:2027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/134\">",
"      Zhu J, Nieto FJ, Horne BD, et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001; 103:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/135\">",
"      Rupprecht HJ, Blankenberg S, Bickel C, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001; 104:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/136\">",
"      Adam E, Melnick JL, Probtsfield JL, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987; 2:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/137\">",
"      Nieto FJ, Adam E, Sorlie P, et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996; 94:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/138\">",
"      Melnick JL, Hu C, Burek J, et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994; 42:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/139\">",
"      Zhou YF, Guetta E, Yu ZX, et al. Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest 1996; 98:2129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/140\">",
"      Zhou YF, Shou M, Guetta E, et al. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation 1999; 100:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/141\">",
"      Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999; 100:e20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/142\">",
"      Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/143\">",
"      Gunn M, Stephens JC, Thompson JR, et al. Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000; 84:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/144\">",
"      Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998; 316:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/145\">",
"      Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002; 105:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/146\">",
"      Prasad A, Zhu J, Halcox JP, et al. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002; 106:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/147\">",
"      Anderson JL, Carlquist JF, Muhlestein JB, et al. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998; 32:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/148\">",
"      Mayr M, Kiechl S, Willeit J, et al. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000; 102:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/149\">",
"      Ott SJ, El Mokhtari NE, Musfeldt M, et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 2006; 113:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/150\">",
"      Stone AF, Mendall MA, Kaski JC, et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation 2002; 106:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/151\">",
"      Meier CR, Derby LE, Jick SS, et al. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA 1999; 281:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/152\">",
"      Erkens JA, Klungel OH, Herings RM, et al. Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients. Eur Heart J 2002; 23:1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/153\">",
"      Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 2002; 105:2143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/154\">",
"      Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/155\">",
"      Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102:3039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/156\">",
"      Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/157\">",
"      Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 78:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/158\">",
"      Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/17/27930/abstract/159\">",
"      Burke AP, Kolodgie FD, Farb A, et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001; 103:934.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13603 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-5450C57513-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27930=[""].join("\n");
var outline_f27_17_27930=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11408436\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27901057\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27901064\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41092387\">",
"      HISTOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901080\">",
"      Fatty streaks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2525668183\">",
"      Fibrous cap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2525668191\">",
"      Vasa vasorum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901087\">",
"      Fibrous plaque",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901094\">",
"      Advanced lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27901102\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901110\">",
"      Endothelial dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901126\">",
"      Inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27901134\">",
"      - Serum CRP",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H41092680\">",
"      - Lp-PLA2",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27901149\">",
"      - Cytokines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27901163\">",
"      - Leukocyte activation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27901170\">",
"      - Toll-like receptor 4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41093640\">",
"      Dyslipidemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41094192\">",
"      Hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41094212\">",
"      Smoking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41094220\">",
"      Diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901191\">",
"      Tissue factor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901199\">",
"      Angiotensin II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901207\">",
"      Endothelin-1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901215\">",
"      Adhesion molecules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901222\">",
"      Flow characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901229\">",
"      Anti-oxidized LDL antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27901244\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27901252\">",
"      - C. pneumoniae infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27901259\">",
"      - Cytomegalovirus infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27901267\">",
"      - Coxsackie B virus infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27901274\">",
"      - H. pylori",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27901282\">",
"      - Pathogen burden",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27901289\">",
"      - Effect of antimicrobial therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27901297\">",
"      - Effect of vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41093121\">",
"      ROLE OF PLAQUE RUPTURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11408436\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/13603\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/13603|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?15/49/16157\" title=\"algorithm 1\">",
"      Role of LDL in atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/13603|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/28/10693\" title=\"diagnostic image 1A\">",
"      Negative remodeling IVUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/18/29989\" title=\"diagnostic image 1B\">",
"      Positive remodeling IVUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/13603|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/16/9472\" title=\"figure 1\">",
"      Early coronary atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/58/35747\" title=\"figure 2\">",
"      Positive and negative remodel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/19/317\" title=\"figure 3\">",
"      Increasing plasma cholesterol and coronary risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/13603|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/18/7468\" title=\"table 1\">",
"      AHA lesion classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/50/812\" title=\"table 2\">",
"      Endothelial dysfunction factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/2/35\" title=\"table 3\">",
"      HDL-C and cardiovascular risk",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36825?source=related_link\">",
"      Actions of angiotensin II on the heart",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35578?source=related_link\">",
"      Approach to the patient with hypertriglyceridemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27658?source=related_link\">",
"      C-reactive protein in cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1482?source=related_link\">",
"      Cardiovascular risk of smoking and benefits of smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25160?source=related_link\">",
"      Chlamydophila (Chlamydia) pneumoniae infection as a potential etiologic factor in atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=related_link\">",
"      Endothelial dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/53/40792?source=related_link\">",
"      Function and clinical applications of immunoglobulins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/18/38186?source=related_link\">",
"      Geriatric health maintenance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/2/39978?source=related_link\">",
"      HDL metabolism and approach to the patient with abnormal HDL-cholesterol levels",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=related_link\">",
"      Intracoronary stent restenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/54/36711?source=related_link\">",
"      Leukocyte-endothelial adhesion in the pathogenesis of inflammation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18138?source=related_link\">",
"      Lipoprotein classification; metabolism; and role in atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40248?source=related_link\">",
"      Lipoprotein(a) and cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/2/32?source=related_link\">",
"      Mechanisms of benefit of lipid-lowering drugs in patients with coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26456?source=related_link\">",
"      Nutritional antioxidants in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/35/27194?source=related_link\">",
"      Overview of hemostasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34394?source=related_link\">",
"      Overview of the possible risk factors for cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=related_link\">",
"      Overview of the risk equivalents and established risk factors for cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/25/44441?source=related_link\">",
"      Pathogenesis of and risk factors for cardiac allograft vasculopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/15/20729?source=related_link\">",
"      Pathology and pathogenesis of the vulnerable plaque",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/5/23635?source=related_link\">",
"      Patient information: Atherosclerosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11592?source=related_link\">",
"      Role of endothelin in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=related_link\">",
"      Seasonal influenza vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/7/25721?source=related_link\">",
"      The role of the vulnerable plaque in acute coronary syndromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_17_27931="BRCA testing USPSTF guidelines";
var content_f27_17_27931=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F57434&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F57434&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations from the United States Preventive Services Task Force on who should be offered genetic testing for BRCA mutations*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        For non-Ashkenazi Jewish women:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Two first-degree relatives with breast cancer, one of whom was diagnosed at age 50 or younger",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A combination of three or more first or second-degree relatives with breast cancer regardless of age at diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A combination of both breast and ovarian cancer among first and second-degree relatives",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A first-degree relative with bilateral breast cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A combination of two or more first or second degree relatives with ovarian cancer, regardless of age at diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A first or second-degree relative with both breast and ovarian cancer at any age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of breast cancer in a male relative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        For women of Ashkenazi Jewish descent:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Any first-degree relative (or two second degree relatives on the same side of the family) with breast or ovarian cancer",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * These recommendations do not apply to women with a family history of breast or ovarian cancer that includes a relative with a known deleterious BRCA mutation.",
"    </div>",
"    <div class=\"reference\">",
"     U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005; 143:355.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27931=[""].join("\n");
var outline_f27_17_27931=null;
var title_f27_17_27932="Hemostasis in preeclampsia";
var content_f27_17_27932=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F72067&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F72067&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Abnormalities of hemostasis reported in preeclampsia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Coagulation and fibrinolysis:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Protein C",
"       </td>",
"       <td>",
"        Normal to decreased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Protein S",
"       </td>",
"       <td>",
"        Decreased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antithrombin III",
"       </td>",
"       <td>",
"        Decreased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tissue plasminogen activator",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plasminogen activator inhibitor I",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plasminogen activator inhibitor II",
"       </td>",
"       <td>",
"        Decreased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombin-activatable fibrinolysis inhibitor",
"       </td>",
"       <td>",
"        Decreased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Soluble fibrin (uterine vein)",
"       </td>",
"       <td>",
"        Decreased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombin-antithrombin III complex",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fibrin D-dimer",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prothrombin fragment 1+2",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombin generation in vitro",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Platelets:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Platelet count",
"       </td>",
"       <td>",
"        Reduced",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Platelet activation",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plasma P-selectin",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plasma beta-thromboglobulin",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Endothelial function:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Flow induced vasodilatation",
"       </td>",
"       <td>",
"        Reduced",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Placental nitric oxide synthase activity",
"       </td>",
"       <td>",
"        Reduced",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Von Willebrand factor",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fibronectin",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Soluble thrombomodulin",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27932=[""].join("\n");
var outline_f27_17_27932=null;
var title_f27_17_27933="Metabolic causes acidosis";
var content_f27_17_27933=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F72299&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F72299&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Laboratory evaluation of metabolic causes of acidosis and coma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Starvation or high fat intake",
"       </td>",
"       <td class=\"subtitle1\">",
"        DKA",
"       </td>",
"       <td class=\"subtitle1\">",
"        Lactic acidosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Uremic acidosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Alcoholic ketosis (starvation)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Salicylate intoxication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Methanol or ethylene glycol intoxication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Hyperosmolar coma",
"       </td>",
"       <td class=\"subtitle1\">",
"        Hypoglycemic coma",
"       </td>",
"       <td class=\"subtitle1\">",
"        Rhabdomyolysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        pH",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &darr;",
"       </td>",
"       <td>",
"        &darr;",
"       </td>",
"       <td>",
"        Mild &darr;",
"       </td>",
"       <td>",
"        &darr;&uarr;",
"       </td>",
"       <td>",
"        &darr;&uarr;*",
"       </td>",
"       <td>",
"        &darr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Mild &darr; may be &darr;&darr;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plasma glucose",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &darr; or normal",
"       </td>",
"       <td>",
"        Normal or &darr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        <p>",
"         &uarr;&uarr;",
"        </p>",
"        <p>",
"         &gt;500mg/dL",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         &darr;&darr;",
"        </p>",
"        <p>",
"         &lt;30 mg/dL",
"        </p>",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glycosuria",
"       </td>",
"       <td>",
"        Negative",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        Negative",
"       </td>",
"       <td>",
"        Negative",
"       </td>",
"       <td>",
"        Negative",
"       </td>",
"       <td>",
"        Negative&bull;",
"       </td>",
"       <td>",
"        Negative",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        Negative",
"       </td>",
"       <td>",
"        Negative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total plasma ketones&Delta;",
"       </td>",
"       <td>",
"        Slight &uarr;",
"       </td>",
"       <td>",
"        &uarr;&uarr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Slight to moderate &uarr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal or slight &uarr;",
"       </td>",
"       <td>",
"        Normal or slight &uarr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anion gap",
"       </td>",
"       <td>",
"        Slight &uarr;",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"       <td>",
"        Slight &uarr;",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal or slight &uarr;",
"       </td>",
"       <td>",
"        &uarr;&uarr;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Osmolality",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &uarr;&uarr;",
"       </td>",
"       <td>",
"        <p>",
"         &uarr;&uarr;",
"        </p>",
"        <p>",
"         &gt;330 mOsm/kg",
"        </p>",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal or slight &uarr;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uric acid",
"       </td>",
"       <td>",
"        Mild (starvation)",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &uarr;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Miscellaneous",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        May give false-positive for ethylene glycol&loz;",
"       </td>",
"       <td>",
"        Serum lactate &gt;7 mmol/l",
"       </td>",
"       <td>",
"        BUN &gt;200 mg/dL",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Serum salicylate positive",
"       </td>",
"       <td>",
"        Serum levels positive",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Myoglobinuria hemoglobinuria",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     +: positive.",
"     <br>",
"      * Acetest and Ketostix measure acetoacetic acid only: thus, misleading low values may be obtained because the majority of \"ketone bodies\" are &beta;-hydroxybutyrate.",
"      <br>",
"       &bull; Respiratory alkalosis/metabolic acidosis.",
"       <br>",
"        &Delta; May get false-positive or false-negative urinary glucose caused by the presence of salicylate or its metabolites.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of Hyperglycemic Crises in Patients with Diabetes. Diabetes Care 2001; 24:131. Copyright &copy; 2006 The American Diabetes Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27933=[""].join("\n");
var outline_f27_17_27933=null;
var title_f27_17_27934="ACEIs in HF in blacks";
var content_f27_17_27934=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71327&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71327&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    ACE inhibitors more effective in whites than blacks with heart failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 362px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown are the rates of hospitalization for heart failure in a matched cohort analysis from the SOLVD trial comparing the responses of black and matched white patients randomly assigned to enalapril or placebo. The rate of hospitalization for heart failure was significantly higher among black than white patients whether treated with enalapril or placebo. Compared to placebo, whites but not blacks had a significant benefit from enalapril therapy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Exner DV, Dries DL, Domanski MJ, Cohn JN. N Engl J Med 2001; 344:1351.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27934=[""].join("\n");
var outline_f27_17_27934=null;
var title_f27_17_27935="Chronic scleritis inflammation";
var content_f27_17_27935=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F81136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F81136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic necrotizing anterior scleritis with inflammation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 332px; height: 215px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chronic necrotizing anterior scleritis with inflammation in a patient with granulomatosis with polyangiitis (Wegener's). Significant thinning of the sclera permits the visualization of the underlying choroid through the scleral wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of M Reza Dana, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_17_27935=[""].join("\n");
var outline_f27_17_27935=null;
